Document ID: EPA-HQ-OPPT-2020-0131-0001
Agency: epa
Document Type: Proposed Rule
Title: Significant New Use Rules on Certain Chemical Substances (20-2.5e)
Posted Date: 2020-10-09T04:00Z

[Federal Register Volume 85, Number 197 (Friday, October 9, 2020)]
[Proposed Rules]
[Pages 64280-64306]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-21471]

[[Page 64279]]

Vol. 85

Friday,

No. 197

October 9, 2020

Part III

Environmental Protection Agency

-----------------------------------------------------------------------

40 CFR PART 721

Significant New Use Rules on Certain Chemical Substances (20-2.5e); 
Proposed Rule

  Federal Register / Vol. 85, No. 197 / Friday, October 9, 2020 / 
Proposed Rules  

[[Page 64280]]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 721

[EPA-HQ-OPPT-2020-0131; FRL-10011-86]
RIN 2070-AB27

Significant New Use Rules on Certain Chemical Substances (20-
2.5e)

AGENCY: Environmental Protection Agency (EPA).

ACTION: Proposed rule.

-----------------------------------------------------------------------

SUMMARY: EPA is proposing significant new use rules (SNURs) under the 
Toxic Substances Control Act (TSCA) for chemical substances that were 
the subject of premanufacture notices (PMNs). The SNURs require persons 
who intend to manufacture (defined by statute to include import) or 
process any of these chemical substances for an activity that is 
proposed as a significant new use by this rule to notify EPA at least 
90 days before commencing that activity. The required notification 
initiates EPA's evaluation of the use, under the conditions of use for 
that chemical substance, within the applicable review period. Persons 
may not commence manufacture or processing for the significant new use 
until EPA has conducted a review of the notice, made an appropriate 
determination on the notice, and has taken such actions as are required 
by that determination.

DATES: Comments must be received on or before November 9, 2020.

ADDRESSES: Submit your comments, identified by docket identification 
(ID) number EPA-HQ-OPPT-2020-0131, through the Federal eRulemaking 
Portal at http://www.regulations.gov. Follow the online instructions 
for submitting comments. Do not submit electronically any information 
you consider to be Confidential Business Information (CBI) or other 
information whose disclosure is restricted by statute.
    Due to the public health concerns related to COVID-19, the EPA 
Docket Center (EPA/DC) and Reading Room is closed to visitors with 
limited exceptions. The staff continues to provide remote customer 
service via email, phone, and webform. For the latest status 
information on EPA/DC services and docket access, visit https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: 
    For technical information contact: William Wysong, Chemical Control 
Division (7405M), Office of Pollution Prevention and Toxics, 
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, 
DC 20460-0001; telephone number: (202) 564-4163; email address: 
wysong.william@epa.gov.
    For general information contact: The TSCA-Hotline, ABVI-Goodwill, 
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 
554-1404; email address: TSCA-Hotline@epa.gov.

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    You may be potentially affected by this action if you manufacture, 
process, or use the chemical substances contained in this proposed 
rule. The following list of North American Industrial Classification 
System (NAICS) codes is not intended to be exhaustive, but rather 
provides a guide to help readers determine whether this document 
applies to them. Potentially affected entities may include:
     Manufacturers or processors of one or more subject 
chemical substances (NAICS codes 325 and 324110), e.g., chemical 
manufacturing and petroleum refineries.
    This action may also affect certain entities through pre-existing 
import certification and export notification rules under TSCA. Chemical 
importers are subject to the TSCA section 13 (15 U.S.C. 2612) import 
provisions promulgated at 19 CFR 12.118 through 12.127 and 19 CFR 
127.28. Chemical importers must certify that the shipment of the 
chemical substance complies with all applicable rules and Orders under 
TSCA, which would include the SNUR requirements should these proposed 
rules be finalized. The EPA policy in support of import certification 
appears at 40 CFR part 707, subpart B. In addition, pursuant to 40 CFR 
721.20, any persons who export or intend to export a chemical substance 
that is the subject of this proposed rule on or after November 9, 2020 
are subject to the export notification provisions of TSCA section 12(b) 
(15 U.S.C. 2611(b)) (see 40 CFR 721.20), and must comply with the 
export notification requirements in 40 CFR part 707, subpart D.

B. What should I consider as I prepare my comments for EPA?

    1. Submitting CBI. Do not submit this information to EPA through 
regulations.gov or email. Clearly mark the part or all of the 
information that you claim to be CBI. For CBI information in a disk or 
CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as 
CBI and then identify electronically within the disk or CD-ROM the 
specific information that is claimed as CBI. In addition to one 
complete version of the comment that includes information claimed as 
CBI, a copy of the comment that does not contain the information 
claimed as CBI must be submitted for inclusion in the public docket. 
Information so marked will not be disclosed except in accordance with 
procedures set forth in 40 CFR part 2.
    2. Tips for preparing your comments. When preparing and submitting 
your comments, see the commenting tips at http://www.epa.gov/dockets/comments.html.

II. Background

A. What action is the Agency taking?

    EPA is proposing these SNURs under TSCA section 5(a)(2) (15 U.S.C. 
2604(a)(2)) for chemical substances that were the subject of PMNs. 
These proposed SNURs would require persons to notify EPA at least 90 
days before commencing the manufacture or processing of any of these 
chemical substances for an activity proposed as a significant new use. 
Receipt of such notices would allow EPA to assess risks and, if 
appropriate, to regulate the significant new use before it may occur.
    The docket for these proposed SNURs, identified as docket ID number 
EPA-HQ-OPPT-2020-0131, includes information considered by the Agency in 
developing these proposed SNURs.

B. What is the Agency's authority for taking this action?

    TSCA section 5(a)(2) (15 U.S.C. 2604(a)(2)) authorizes EPA to 
determine that a use of a chemical substance is a ``significant new 
use.'' EPA must make this determination by rule after considering all 
relevant factors, including the four TSCA section 5(a)(2) factors 
listed in Unit III.

C. Applicability of General Provisions

    General provisions for SNURs appear in 40 CFR part 721, subpart A. 
These provisions describe persons subject to the rule, recordkeeping 
requirements, exemptions to reporting requirements, and applicability 
of the rule to uses occurring before the effective date of the rule. 
Provisions relating to user fees appear at 40 CFR part 700. Pursuant to 
40 CFR 721.1(c), persons subject to these SNURs must comply with the 
same significant new use notice (SNUN) requirements and EPA regulatory 
procedures as submitters of PMNs under TSCA section 5(a)(1)(A). These 
requirements include the information submission requirements of TSCA 
sections 5(b) and 5(d)(1), the exemptions authorized by TSCA

[[Page 64281]]

sections 5(h)(1), (h)(2), (h)(3), and (h)(5), and the regulations at 40 
CFR part 720. Once EPA receives a SNUN and before the manufacture or 
processing for the significant new use can commence, EPA must either 
determine that the use is not likely to present an unreasonable risk of 
injury under the conditions of use for the chemical substance or take 
such regulatory action as is associated with an alternative 
determination. If EPA determines that the use is not likely to present 
an unreasonable risk, EPA is required under TSCA section 5(g) to make 
public, and submit for publication in the Federal Register, a statement 
of EPA's findings.

III. Significant New Use Determination

    TSCA section 5(a)(2) states that EPA's determination that a use of 
a chemical substance is a significant new use must be made after 
consideration of all relevant factors, including:
     The projected volume of manufacturing and processing of a 
chemical substance.
     The extent to which a use changes the type or form of 
exposure of human beings or the environment to a chemical substance.
     The extent to which a use increases the magnitude and 
duration of exposure of human beings or the environment to a chemical 
substance.
     The reasonably anticipated manner and methods of 
manufacturing, processing, distribution in commerce, and disposal of a 
chemical substance.
    In determining what would constitute a significant new use for the 
chemical substances that are the subject of these SNURs, EPA considered 
relevant information about the toxicity of the chemical substances, 
potential human exposures and environmental releases that may be 
associated with possible uses of these chemical substances, in the 
context of the four TSCA section 5(a)(2) factors listed in this unit.
    The proposed rules include PMN substances that are subject to 
Orders issued under TSCA section 5(e)(1)(A), as required by the 
determinations made under TSCA section 5(a)(3)(B). The TSCA Orders 
require protective measures to limit exposures or otherwise mitigate 
the potential unreasonable risk. The proposed SNURs identify 
significant new uses as any manufacturing, processing, use, 
distribution in commerce, or disposal that does not conform to the 
restrictions imposed by the underlying TSCA Orders, consistent with 
TSCA section 5(f)(4).
    Where EPA determined that the PMN substance may present an 
unreasonable risk of injury to human health via inhalation exposure, 
the underlying TSCA Order usually requires that potentially exposed 
employees wear specified respirators unless actual measurements of the 
workplace air show that air-borne concentrations of the PMN substance 
are below a New Chemical Exposure Limit (NCEL), and includes 
requirements addressing performance criteria for sampling and 
analytical methods, periodic monitoring, respiratory protection, and 
recordkeeping. No comparable NCEL provisions currently exist in 40 CFR 
part 721, subpart B, for SNURs. Therefore, for these cases, the 
individual SNURs in 40 CFR part 721, subpart E, will state that persons 
subject to the SNUR who wish to pursue NCELs as an alternative to the 
40 CFR 721.63 respirator requirements may request to do so under 40 CFR 
721.30. EPA expects that persons whose 40 CFR 721.30 requests to use 
the NCELs approach for SNURs that are approved by EPA will be required 
to comply with NCELs provisions that are comparable to those contained 
in the corresponding TSCA Order for the same chemical substance.
    These proposed rules include PMN substances that received ``not 
likely to present an unreasonable risk'' determination in TSCA section 
5(a)(3)(c). However, during the course of these reviews, EPA identified 
concerns for certain health and/or environmental risks if the chemicals 
were not used following the limitations identified by the submitters in 
the notices. The proposed SNURs would identify as significant new uses 
any manufacturing, processing, use, distribution in commerce, or 
disposal that does not conform to the protection measures.

IV. Substances Subject to This Proposed Rule

    EPA is proposing significant new use and recordkeeping requirements 
for certain chemical substances in 40 CFR part 721, subpart E. In this 
unit, EPA provides the following information for each chemical 
substance that is identified in this unit as subject to this proposed 
rule:
     PMN number.
     Chemical name (generic name, if the specific name is 
claimed as CBI).
     Chemical Abstracts Service (CAS) Registry number (if 
assigned for non-confidential chemical identities).
     Basis for the SNUR or TSCA Order.
     Effective date of the TSCA Order (if applicable).
     Potentially Useful Information.
     CFR citation assigned in the regulatory text section of 
the proposed rule.
    The chemicals subject to these proposed SNURs are as follows:
    PMN Numbers: P-18-241, P-18-244, and P-18-245.
    Chemical Names: 2-Propenoic acid, 2-methyl-, methyl ester, polymer 
with ethenylbenzene, ethyl 2-propenoate, 2-oxiranylmethyl 2-methyl-2-
propenoate and 1,2-propanediol mono(2-methyl-2-propenoate), reaction 
products with diethanolamine, polymers with substituted-alkyl acrylate, 
formats (salts) (P-18-241) (generic); 2-Propenoic acid, 2-methyl, 
methyl ester, polymer with ethenylbenzene, ethyl 2-propenoate, 2-
oxiranylmethyl 2-methyl-2-propenoate and 1,2-propanediol mono(2-methyl-
2-propenoate), reaction products with diethanolamine, polymers with 
substituted-alkyl methacrylate, formats (salts) (P-18-244) (generic); 
2-Propenoic acid, 2-methyl-, methyl ester, polymer with ethenylbenzene, 
ethyl 2-propenoate, 2-oxrianylmethyl 2-methyl-2-propenoate, and 1,2-
propaneidol mono(2-methyl-2-propenoate), reaction products with 
diethanolamine, polymers with alkylene glycol monoacrylate, formats 
(salts) (P-18-245) (generic).
    CAS Numbers: Not available.
    Basis for the action: The PMNs state that the generic (non-
confidential) use of the substances will be as additives for automotive 
coatings. EPA estimated the human health hazard of the chemical 
substances based on their measured and estimated physical/chemical 
properties and by comparison with structurally analogous chemical 
substances. EPA determined environmental hazard for the new chemical 
substances based on Structural Activity Relationships (SAR) analysis 
for polycationic polymers. EPA has identified concerns for potential 
neurotoxicity, blood toxicity, reproductive and developmental toxicity, 
and moderate environmental hazard if the chemical substances are not 
manufactured and not used following the limitations identified by the 
submitters in the notices. This proposed SNUR designates the following 
circumstances of use as ``significant new uses'' requiring further 
review by EPA:
     Use of the PMN substances other than as described in the 
PMNs.
    Potentially useful information: EPA has determined that information 
about the human health and environmental effects of the PMN substances 
may be potentially useful if a manufacturer or processor is considering 
submitting a SNUN for a significant new use that would be designated by 
this proposed SNUR. EPA has determined that the results of 
neurotoxicity, reproductive/developmental toxicity, and aquatic

[[Page 64282]]

toxicity testing would help characterize the potential health and 
environmental effects of the PMN substances.
    CFR Citations: 40 CFR 721.11401 (P-18-241), 40 CFR 721.11402 (P-18-
244), and 40 CFR 721.11403 (P-18-245).

    PMN Numbers: P-16-539, P-18-157, P-18-158, P-18-159, and P-19-33.
    Chemical Names: Organic sulfonate compound (generic) (P-16-539), 
thiophenium, 1-(2,7-disubstituted-1-naphthalenyl)tetrahydro-, salt with 
polyfluoro-N-polyfluoroalkylsulfonyl-1-alkanesulfonamide (1:1) 
(generic) (P-18-157), sulfonium, triphenyl-, salt with 2,3-
bis(substituted) 5-sulfocarbopolycyclic-2,3-carboxylate derivative 
(1:1) (generic) (P-18-158), thiophenium, 1-(2,7-disubstituted-1-
naphthalenyl)tetrahydro-, salt with polyfluoro-N-
polyfluoroalkylsulfonyl-1-alkanesulfonamide (1:1) (P-18-159), and 
sulfonium, triphenyl-, 5-(alkyl) fluoropentane derivative (generic) (P-
19-33).
    CAS Numbers: Not available.
    Effective Date of TSCA Order: January 31, 2020.
    Basis for TSCA Order: The PMNs state that the generic (non-
confidential) use of the substances will be for photolithography (P-16-
539, P-18-158, and P-19-33) and as a photosensitizer for photoresist 
(P-18-158 and P-18-159). Based on the physical/chemical properties of 
the PMN substances and test data on structurally similar substances, 
the PMN substances are potentially persistent, bioaccumulative, and 
toxic (PBT) chemicals (as described in the New Chemical Program's PBT 
category policy statement (64 FR 60194, November 4, 1999; FRL-6097-7)). 
EPA estimates that the PMN substances will persist in the environment 
for more than 2 months and estimates a bioaccumulation factor of 
greater than or equal to 1,000. Based on physical/chemical properties 
and comparison with analogous chemical substances, EPA has also 
identified concerns for photosensitization, eye corrosion, irritation, 
acute toxicity, neurotoxicity, lung overload, aquatic toxicity, and 
reproductive/developmental toxicity. The TSCA Order was issued under 
TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a 
finding that in the absence of sufficient information to permit a 
reasoned evaluation, the substances may present an unreasonable risk of 
injury to human health or the environment. To protect against these 
risks, the TSCA Order requires:
    1. No manufacture of any of the PMN substances beyond the time 
limits specified in the TSCA Order without submittal to EPA of the 
results of certain testing described in the Testing section of the TSCA 
Order;
    2. Use of personal protective equipment where there is a potential 
for dermal exposure;
    3. Establishment of a hazard communication program, including human 
health precautionary statements on each label and in the Safety Data 
Sheet (SDS);
    4. No modification of the processing of the PMN substances in any 
way that generates a dust, mist, or aerosol in a non-enclosed process;
    5. Use of the PMN substances only as described in the TSCA Order;
    6. No domestic manufacture of the PMN substances (i.e., import 
only);
    7. Import of the PMN substances only in solution, or in any form in 
sealed containers weighing 5 kilograms or less; and
    8. No exceedance of the confidential annual production volumes 
listed in the TSCA Order.
    The proposed SNUR would designate as a ``significant new use'' the 
absence of these protective measures.
    Potentially Useful Information: EPA has determined that certain 
information about the physical/chemical properties, fate, 
bioaccumulation, environmental hazard, and human health effects of the 
PMN substance may be potentially useful in support of a request by the 
PMN submitter to modify the TSCA Order, or if a manufacturer or 
processor is considering submitting a SNUN for a significant new use 
that will be designated by this SNUR. The submitter has agreed not to 
exceed the time limits specified in the TSCA Order without performing 
the required Tier I and Tier II testing outlined in the Testing section 
of the TSCA Order.
    CFR Citations: 40 CFR 721.11514 (P-16-539), 40 CFR 721.11515 (P-18-
157), 40 CFR 721.11516 (P-18-158), 40 CFR 721.11517 (P-18-159), and 40 
CFR 721.11518 (P-19-33).

    PMN Numbers: P-17-178, P-18-13, P-18-14, P-18-37, P-19-78, P-19-79, 
P-19-111, P-19-112, P-19-114 and P-19-133.
    Chemical Names: Sulfonium, triphenyl-, salt with substituted-alkyl 
4-substituted-benzoate (generic) (P-17-178), substituted-
triphenylsulfonium, inner salt (generic) (P-18-13), sulfonium, 
triphenyl-, salt with disubstituted-heterocyclic compound (1:1) 
(generic) (P-18-14), sulfonium, triphenyl-, salt with 2,4,5-
trisubstituted-benzenesulfonate (1:1) (generic) (P-18-37), substituted 
heterocyclic onium compound, salt with 2,2,2-trifluoro-1-(sulfomethyl)-
1-(trifluoromethyl)ethyl 3-[(2-methyl-1-oxo-2-propen-1-
yl)oxy]tricyclo[3.3.1.13,7]decane-1-carboxylate (1:1), polymer with 
acenaphthylene, 1-ethenyl-4-[(1-ethylcyclopentyl)oxy]benzene and 4-
ethenylphenol, di-Me 2,2'-(1,2-diazenediyl)bis[2-methylpropanoate]-
initiated (generic) (P-19-78), substituted heterocyclic onium compound, 
salt with 2,2,2-trifluoro-1-(sulfomethyl)-1-(trifluoromethyl)ethyl 3-
[(2-methyl-1-oxo-2-propen-1-yl)oxy]tricyclo[3.3.1.13,7]decane-1-
carboxylate (1:1), polymer with acenaphthylene 1-ethenyl-4-[[1-(1-
methylethyl)cyclopentyl]oxy]benzene and 4-ethenylphenol, di-Me 2,2'-
(1,2-diazenediyl)bis[2-methylpropanoate]-initiated (generic) (P-19-79), 
dibenzothiophenium, aryl substituted trifluoro-hydroxy-
(triheterosubstitutedalkyl)alkanoate (1:1) (generic) (P-19-111), 
substituted heterocyclic onium compound, salt with 1-
(difluorosulfomethyl)-2,2,2-trifluoroethyl 3-[(2-methyl-1-oxo-2-propen-
1-yl)oxy]tricyclo[3.3.1.13,7]decane-1-carboxylate (1:1), polymer with 
3-ethenylphenol, 1-(1-methylethyl)cyclopentyl 2-methyl-2-propenoate and 
1-(7-oxabicyclo[2.2.1]hept-2-yl)cyclopentyl 2-methyl-2-propenoate, di-
Me 2,2'-(1,2-diazenediyl)bis[2-methylpropenoate]-initiated (generic) 
(P-19-112), sulfonium, triphenyl-, trifluoro-hydroxy-
(triheterosubstitutedalkyl)alkanoate (1:1) (generic) (P-19-114), and 
heterotrisubstituted-bile acid, 1-(difluorosulfomethyl)-2,2,2-
trifluoroethyl ester, ion(1-), (5)-, triphenylsulfonium (1:1) (generic) 
(P-19-133).
    CAS Numbers: Not available.
    Effective Date of TSCA Order: January 31, 2020.
    Basis for TSCA Order: The PMNs state that the generic (non-
confidential) uses of the substances will be for microlithography for 
electronic device manufacturing (P-17-178, P-18-13, P-18-14, and P-18-
37), polymers for photo resist (P-19-78 and P-17-79), and 
microlithography for electronic device manufacturing (P-19-78, P-19-79, 
P-19-111, P-19-112, P-19-114, and P-19-133). Based on the physical/
chemical properties of the PMN substances and test data on structurally 
similar substances, the PMN substances are potentially PBT chemicals 
(as described in the New Chemical Program's PBT category policy 
statement (64 FR 60194, November 4, 1999; FRL-6097-7)). EPA estimates 
that the PMN substances will persist in the environment more than 2 
months and estimates a bioaccumulation factor of

[[Page 64283]]

greater than or equal to 1,000. Based on physical/chemical properties 
and comparison with analogous chemical substances, EPA has also 
identified concerns for photosensitization, eye corrosion, irritation, 
acute toxicity, neurotoxicity, lung overload, aquatic toxicity, and 
reproductive/developmental toxicity. The Order was issued under TSCA 
sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding 
that in the absence of sufficient information to permit a reasoned 
evaluation, the substances may present an unreasonable risk of injury 
to human health or the environment. To protect against these risks, the 
TSCA Order requires:
    1. No manufacture of any of the PMN substances beyond the time 
limits specified in the TSCA Order without submittal to EPA of the 
results of certain testing described in the Testing section of the TSCA 
Order;
    2. Use of personal protective equipment where there is a potential 
for dermal exposure;
    3. Establishment of a hazard communication program, including human 
health precautionary statements on each label and in the SDS;
    4. No modification of the processing of the PMN substances in any 
way that generates a dust, mist, or aerosol in a non-enclosed process;
    5. Use of the PMN substances only as described in the TSCA Order;
    6. No domestic manufacture of the PMN substances (i.e., import 
only);
    7. Import of the PMN substances only in solution, or in any form in 
sealed containers weighing 5 kilograms or less; and
    8. No exceedance of the confidential annual importation volumes 
listed in the TSCA Order.
    The proposed SNUR would designate as a ``significant new use'' the 
absence of these protective measures.
    Potentially Useful Information: EPA has determined that certain 
information about the physical/chemical properties, fate, 
bioaccumulation, environmental hazard, and human health effects of the 
PMN substance may be potentially useful in support of a request by the 
PMN submitter to modify the TSCA Order, or if a manufacturer or 
processor is considering submitting a SNUN for a significant new use 
that will be designated by this SNUR. The submitter has agreed not to 
exceed the time limits specified in the TSCA Order without performing 
the required Tier I and Tier II testing outlined in the Testing section 
of the TSCA Order.
    CFR Citations: 40 CFR 721.11519 (P-17-178), 40 CFR 721.11520 (P-18-
13), 40 CFR 721.11521 (P-18-14), 40 CFR 721.11522 (P-18-37), 40 CFR 
721.11523 (P-19-78), 40 CFR 721.11524 (P-19-79), 40 CFR 721.11525 (P-
19-111), 40 CFR 721.11526 (P-19-112), 40 CFR 721.11527 (P-19-114), and 
40 CFR 721.11528 (P-19-133).

    PMN Number: P-18-16.
    Chemical Name: Aromatic sulfonium tricyclo fluoroalkyl sulfonic 
acid salt (generic).
    CAS Number: None available.
    Effective Date of TSCA Order: February 11, 2020.
    Basis for TSCA Order: The PMN states that the generic (non-
confidential) use will be as a photoacid generator (PAG). Based on the 
physical/chemical properties of the PMN substance, the PMN substance is 
a potentially PBT chemical (as described in the New Chemical Program's 
PBT category policy statement (64 FR 60194, November 4, 1999; FRL-6097-
7)). EPA estimates that the PMN substance will persist in the 
environment for more than 2 months and estimates a bioaccumulation 
factor of greater than or equal to 1,000. Based on physical/chemical 
properties and comparison with analogous chemical substances, EPA has 
also identified concerns for photosensitization, eye corrosion, 
irritation, acute toxicity, liver toxicity, neurotoxicity, 
reproductive/developmental toxicity, and aquatic toxicity. The Order 
was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), 
based on a finding that in the absence of sufficient information to 
permit a reasoned evaluation, the substance may present an unreasonable 
risk of injury to human health or the environment. To protect against 
these risks, the TSCA Order requires:
    1. No manufacture of the PMN substance beyond the time limits 
specified in the TSCA Order without submittal to EPA of the results of 
certain testing described in the Testing section of the TSCA Order;
    2. Use of personal protective equipment where there is a potential 
for dermal exposure;
    3. Establishment of a hazard communication program, including human 
health precautionary statements on each label and in the SDS;
    4. No modification of the processing of the PMN substance in any 
way that generates a dust, mist, or aerosol in a non-enclosed process;
    5. Use of the PMN substance only as described in the TSCA Order;
    6. No domestic manufacture of the PMN substance (i.e., import 
only);
    7. Import of the PMN substance only in solution, or in any form in 
sealed containers weighing 5 kilograms or less; and
    8. No exceedance of the confidential annual importation volume 
listed in the TSCA Order.
    The proposed SNUR would designate as a ``significant new use'' the 
absence of these protective measures.
    Potentially Useful Information: EPA has determined that certain 
information about the physical/chemical properties, fate, 
bioaccumulation, environmental hazard, and human health effects of the 
PMN substance may be potentially useful in support of a request by the 
PMN submitter to modify the TSCA Order, or if a manufacturer or 
processor is considering submitting a SNUN for a significant new use 
that will be designated by this SNUR. The submitter has agreed not to 
exceed the time limits specified in the TSCA Order without performing 
the required Tier I and Tier II testing outlined in the Testing section 
of the TSCA Order.
    CFR Citation: 40 CFR 721.11529.

    PMN Numbers: P-18-297, P-18-311, P-18-314, and P-18-315.
    Chemical Names: Substituted, (alkylaromatic)diaromatic salt with 
trihalo-[(trihaloalkyl)substituted]substituted alkaneamide (generic) 
(P-18-297), triarylsulfonium substituted oxatricycloalkyloxycarbonyl 
dihalo alkane sulfonate (generic) (P-18-311), substituted 
triarylsulfonium carbopolycyclic heteromonocyclic dihalo sulfoacetate 
(generic) (P-18-314), and substituted triarylsulfonium substituted 
carbopolycyclic carboxylate (generic) (P-18-315).
    CAS Numbers: Not available.
    Effective Date of TSCA Order: February 4, 2020.
    Basis for TSCA Order: The PMNs state that the generic (non-
confidential) use of the substances will be as components of material 
for fabrication. Based on the physical/chemical properties of the PMN 
substances and test data on structurally similar substances, the PMN 
substances are potentially PBT chemicals (as described in the New 
Chemical Program's PBT category policy statement (64 FR 60194, November 
4, 1999; FRL-6097-7)). EPA estimates that the PMN substances will 
persist in the environment more than 2 months and estimates a 
bioaccumulation factor of greater than or equal to 1,000. Based on 
physical/chemical properties and comparison with analogous chemical 
substances, EPA has also identified concerns for photosensitization, 
eye corrosion, irritation, acute toxicity, neurotoxicity, lung 
overload, aquatic toxicity, and reproductive/developmental toxicity. 
The Order was issued under TSCA sections

[[Page 64284]]

5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the 
absence of sufficient information to permit a reasoned evaluation, the 
substances may present an unreasonable risk of injury to human health 
or the environment. To protect against these risks, the TSCA Order 
requires:
    1. No manufacture of any of the PMN substances beyond the time 
limits specified in the TSCA Order without submittal to EPA of the 
results of certain testing described in the Testing section of the TSCA 
Order;
    2. Use of personal protective equipment where there is a potential 
for dermal exposure;
    3. Establishment of a hazard communication program, including human 
health precautionary statements on each label and in the SDS;
    4. No modification of the processing of the PMN substances in any 
way that generates a dust, mist, or aerosol in a non-enclosed process;
    5. Use of the PMN substances only as described in the TSCA Order;
    6. No domestic manufacture of the PMN substances (i.e., import 
only);
    7. Import of the PMN substances only in solution, or in any form in 
sealed containers weighing 5 kilograms or less; and
    8. No exceedance of the confidential annual importation volumes 
listed in the TSCA Order.
    The proposed SNUR would designate as a ``significant new use'' the 
absence of these protective measures.
    Potentially Useful Information: EPA has determined that certain 
information about the physical/chemical properties, fate, 
bioaccumulation, environmental hazard, and human health effects of the 
PMN substance may be potentially useful in support of a request by the 
PMN submitter to modify the TSCA Order, or if a manufacturer or 
processor is considering submitting a SNUN for a significant new use 
that will be designated by this SNUR. The submitter has agreed not to 
exceed the time limits specified in the TSCA Order without performing 
the required Tier I and Tier II testing outlined in the Testing section 
of the TSCA Order.
    CFR Citations: 40 CFR 721.11530 (P-18-297), 40 CFR 721.11531 (P-18-
311), 40 CFR 721.11532 (P-18-314), and 40 CFR 721.11533 (P-18-315).

    PMN Numbers: P-18-304, P-18-316, P-18-338, P-19-76, P-19-115, and 
P-19-142.
    Chemical Names: Sulfonium, bis(dihalocarbomonocycle) 
carbomonocycle, salt with substituted heteropolycycle dihalo 
sulfoalkanoate (1:1) (generic) (P-18-304), heteropolycycle, 
alkylaromatic-, salt with dihalo-substituted alkyl carbopolycycle 
carboxylate (generic) (P-18-316), sulfonium, triaryl-, salt with 
polyhalo-4-sulfoalkyl polycarbocyclic alkane-1-carboxylate (1:1) (P-18-
338), sulfonium, bis(dihalocarbomonocycle) carbomonocycle, salt with 
dihalo substituted alkyl carbopolycyclic carboxylate (1:1) (generic) 
(P-19-76), sulfonium, bis(dihalocarbomonocycle) carbomonocycle, 
substituted carbomonocyclic ester (generic) (P-19-115), and 
heteropolycycle, aromatic-, salt with dihalo-substituted alkyl 
carbopolycycle carboxylate (1:1) (generic) (P-19-142).
    CAS Numbers: Not available.
    Effective Date of TSCA Order: January 30, 2020.
    Basis for TSCA Order: The PMNs state that the generic (non-
confidential) use of the substances will be as ingredients used in the 
manufacture of photoresist. Based on the physical/chemical properties 
of the PMN substances and test data on structurally similar substances, 
the PMN substances are potentially PBT chemicals (as described in the 
New Chemical Program's PBT category policy statement (64 FR 60194, 
November 4, 1999; FRL-6097-7)). EPA estimates that the PMN substances 
will persist in the environment more than 2 months and estimates a 
bioaccumulation factor of greater than or equal to 1,000. Based on 
physical/chemical properties and comparison with analogous chemical 
substances, EPA has also identified concerns for photosensitization, 
eye corrosion, irritation, acute toxicity, neurotoxicity, lung 
overload, aquatic toxicity, and reproductive/developmental toxicity. 
The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 
5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient 
information to permit a reasoned evaluation, the substances may present 
an unreasonable risk of injury to human health or the environment. To 
protect against these risks, the TSCA Order requires:
    1. No manufacture of any of the PMN substances beyond the time 
limits specified in the TSCA Order without submittal to EPA of the 
results of certain testing described in the Testing section of the TSCA 
Order;
    2. Use of personal protective equipment where there is a potential 
for dermal exposure;
    3. Establishment of a hazard communication program, including human 
health precautionary statements on each label and in the SDS;
    4. No modification of the processing of the PMN substances in any 
way that generates a dust, mist, or aerosol in a non-enclosed process;
    5. Use of the PMN substances only as described in the PMNs;
    6. No domestic manufacture of the PMN substances (i.e., import 
only);
    7. Import of the PMN substances only in solution, or in any form in 
sealed containers weighing 5 kilograms or less; and
    8. No exceedance of the confidential annual importation volumes 
listed in the TSCA Order.
    The proposed SNUR would designate as a ``significant new use'' the 
absence of these protective measures.
    Potentially Useful Information: EPA has determined that certain 
information about the physical/chemical properties, fate, 
bioaccumulation, environmental hazard, and human health effects of the 
PMN substance may be potentially useful in support of a request by the 
PMN submitter to modify the TSCA Order, or if a manufacturer or 
processor is considering submitting a SNUN for a significant new use 
that will be designated by this SNUR. The submitter has agreed not to 
exceed the time limits specified in the TSCA Order without performing 
the required Tier I and Tier II testing outlined in the Testing section 
of the TSCA Order.
    CFR Citations: 40 CFR 721.11534 (P-18-304), 40 CFR 721.11535 (P-18-
316), 40 CFR 721.11536 (P-18-338), 40 CFR 721.11537 (P-19-76), 40 CFR 
721.11538 (P-19-115), and 40 CFR 721.11539 (P-19-142).

    PMN Number: P-19-166.
    Chemical Name: Triarylsulfonium alkylestersulfonate (generic).
    CAS Number: None available.
    Effective Date of TSCA Order: February 12, 2020.
    Basis for TSCA Order: The PMN states that the generic (non-
confidential) use will be as a photoacid generator (PAG). Based on the 
physical/chemical properties of the PMN substance, the PMN substance is 
a potentially persistent, bioaccumulative, and toxic (PBT) chemical (as 
described in the New Chemical Program's PBT category at 64 FR 60194; 
November 1999). EPA estimates that the PMN substance will persist in 
the environment for more than 2 months and estimates a bioaccumulation 
factor of greater than or equal to 1,000. Based on physical/chemical 
properties and comparison with analogous chemical substances, EPA has 
also identified concerns for photosensitization, eye corrosion, 
irritation, acute toxicity, liver toxicity, neurotoxicity, 
reproductive/developmental toxicity, and aquatic toxicity. The Order 
was issued under

[[Page 64285]]

TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a 
finding that in the absence of sufficient information to permit a 
reasoned evaluation, the substance may present an unreasonable risk of 
injury to human health or the environment. To protect against these 
risks, the TSCA Order requires:
    1. No manufacture of the PMN substance beyond the time limits 
specified in the TSCA Order without submittal to EPA of the results of 
certain testing described in the Testing section of the TSCA Order;
    2. Use of personal protective equipment where there is a potential 
for dermal exposure;
    3. Establishment of a hazard communication program, including human 
health precautionary statements on each label and in the SDS;
    4. No modification of the processing of the PMN substance in any 
way that generates a dust, mist, or aerosol in a non-enclosed process;
    5. Use of the PMN substance only as described in the TSCA Order;
    6. No domestic manufacture of the PMN substance (import only);
    7. Import of the PMN substance only in solution, or in any form in 
sealed containers weighing 5 kilograms or less; and
    8. No exceedance of the confidential annual importation volume 
listed in the TSCA Order.
    The proposed SNUR would designate as a ``significant new use'' the 
absence of these protective measures.
    Potentially Useful Information: EPA has determined that certain 
information about the physical/chemical properties, fate, 
bioaccumulation, environmental hazard, and human health effects of the 
PMN substance may be potentially useful in support of a request by the 
PMN submitter to modify the TSCA Order, or if a manufacturer or 
processor is considering submitting a SNUN for a significant new use 
that will be designated by this SNUR. The submitter has agreed not to 
exceed the time limits specified in the TSCA Order without performing 
the required Tier I and Tier II testing outlined in the Testing section 
of the TSCA Order.
    CFR Citation: 40 CFR 721.11540.

    PMN Numbers: P-19-168, P-19-169, P-19-171, P-19-172, P-19-173, P-
19-175, P-19-176, P-19-177, P-19-178, P-19-179, P-19-180, P-19-181, P-
19-182, P-19-184, and P-19-187.
    Chemical Names: Halogenated alkylbenzoic acid (generic) (P-19-168, 
P-19-169, P-19-175, P-19-176, P-19-177, P-19-178, and P-19-179), 
halogenated benzoic acid (P-19-171, P-19-172, and P-19-173), 
halogenated sodium benzoate (P-19-180, P-19-181, and P-19-182), and 
halogenated sodium alkylbenzoate (P-19-184 and P-19-187).
    CAS Numbers: Not available.
    Effective Date of TSCA Order: January 31, 2020.
    Basis for TSCA Order: The PMNs states that the generic (non-
confidential) use will be to monitor oil and gas well performance (P-
19-180, P-19-181, P-19-182, P-19-184, and P-19-187) and as well 
performance tracers (P-19-168, P-19-169, P-19-171, P-19-172, P-19-173, 
P-19-175, P-19-176, P-19-177, P-19-178, and P-19-179). Based on the 
estimated physical/chemical properties of the PMN substances and 
comparison with analogous chemical substances, EPA has identified 
concerns for developmental toxicity and neurotoxicity for all of the 
PMN substances and additionally irritation to skin, eyes, and 
respiratory tract for P-19-168, P-19-169, P-19-171, P-19-172, P-19-173, 
P-19-175, P-19-176, P-19-177, P-19-178, and P-19-179. The Order was 
issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), 
based on a finding that in the absence of sufficient information to 
permit a reasoned evaluation, the substances may present an 
unreasonable risk of injury to human health or the environment. To 
protect against these risks, the TSCA Order requires:
    1. No manufacture (including import), processing, or use of any of 
the PMN substances other than for the confidential use described in 
each PMN;
    2. Submission to EPA of certain toxicity testing before 
manufacturing (including import) beyond the confidential cumulative 
production volumes listed in the Testing Section of the TSCA Order;
    3. Use of personal protective equipment where there is a potential 
for dermal exposure to PMN substances P-19-168, P-19-169, P-19-171, P-
19-172, P-19-173, P-19-175, P-19-176, P-19-177, P-19-178, or P-19-179;
    4. Use of engineering controls/processes as specified in the TSCA 
Order;
    5. Use of a NIOSH-certified respirator with an APF of at least 10 
where there is a potential for inhalation exposure to PMN substances P-
19-168, P-19-169, P-19-171, P-19-172, P-19-173, P-19-175, P-19-176, P-
19-177, P-19-178, or P-19-179 or compliance with a NCEL of 0.0195 mg/
m\3\ as an 8-hour time-weighted average to prevent inhalation exposure;
    6. Establishment and use of a hazard communication program, 
including human health precautionary statements on each label and in 
the SDS;
    7. No manufacture or use of PMN substances P-19-180, P-19-181, P-
19-182, P-19-184, or P-19-187 other than in liquid formulations; and
    8. No manufacture of the PMN substances P-19-168, P-19-169, P-19-
171, P-19-172, P-19-173, P-19-175, P-19-176, P-19-177, P-19-178, or P-
19-179 beyond the confidential annual production volume limit specified 
in the TSCA Order.
    The proposed SNUR would designate as a ``significant new use'' the 
absence of these protective measures.
    Potentially Useful Information: EPA has determined that certain 
information about the human health effects of the PMN substances may be 
potentially useful in support of a request by the PMN submitter to 
modify the TSCA Order, or if a manufacturer or processor is considering 
submitting a SNUN for a significant new use that will be designated by 
this SNUR. EPA has determined that the results of skin irritation, eye 
damage, neurotoxicity, reproductive/developmental toxicity, pulmonary 
effects, and specific target organ toxicity testing may be potentially 
useful to characterize the human health effects of the PMN substances. 
Although the TSCA Order does not require these tests, the TSCA Order's 
restrictions remain in effect until the TSCA Order is modified or 
revoked by EPA based on submission of this or other relevant 
information.
    CFR Citations: 40 CFR 721.11541 (P-19-168), 40 CFR 721.11542 (P-19-
169), 40 CFR 721.11543 (P-19-171), 40 CFR 721.11544 (P-19-172), 40 CFR 
721.11545 (P-19-173), 40 CFR 721.11546 (P-19-175), 40 CFR 721.11547 (P-
19-176), 40 CFR 721.11548 (P-19-177), 40 CFR 721.11549 (P-19-178), 40 
CFR 721.11550 (P-19-179), 40 CFR 721.11551 (P-19-180), 40 CFR 721.11552 
(P-19-181), 40 CFR 721.11553 (P-19-182), 40 CFR 721.11554 (P-19-184), 
and 40 CFR 721.11555 (P-19-187).

V. Rationale and Objectives of the Proposed Rule

A. Rationale

    During review of the PMNs submitted for some of the chemical 
substances that are the subject to these proposed SNURs, EPA concluded 
that regulation was warranted under TSCA section 5(e), pending the 
development of information sufficient to make reasoned evaluations of 
the health or environmental effects of the chemical substances. The 
basis for such findings is outlined in Unit IV. Based on these 
findings, TSCA section 5(e) Orders requiring the use of

[[Page 64286]]

appropriate exposure controls were negotiated with the PMN submitters. 
As a general matter, EPA believes it is necessary to follow the TSCA 
Orders with a SNUR that identifies the absence of those protective 
measures as significant new uses to ensure that all manufacturers and 
processors--not just the original submitter--are held to the same 
standard.
    During review of the other chemical substances that are the subject 
of these proposed SNURs and as further discussed in Unit IV., EPA 
identified certain other circumstances of use different from the 
intended conditions of use identified in the PMNs and determined that 
those changes could result in changes in the type or form of exposure 
to the chemical substances and/or increased exposures to the chemical 
substances and/or changes in the reasonably anticipated manner and 
methods of manufacturing, processing, distribution in commerce, and 
disposal of the chemical substances.

B. Objectives

    EPA is proposing these SNURs for specific chemical substances which 
have undergone premanufacture review because the Agency wants:
     To identify as significant new uses any manufacturing, 
processing, use, distribution in commerce, or disposal that does not 
conform to the restrictions imposed by the underlying TSCA Orders, 
consistent with TSCA section 5(f)(4).
     To have an opportunity to review and evaluate data 
submitted in a SNUN before the notice submitter begins manufacturing or 
processing a listed chemical substance for the described significant 
new use.
     To be able to either determine that the prospective 
manufacture or processing is not likely to present an unreasonable 
risk, or to take necessary regulatory action associated with any other 
determination, before the described significant new use of the chemical 
substance occurs.

VI. Applicability of the Proposed Significant New Use Designation

    To establish a significant new use, EPA must determine that the use 
is not ongoing. The chemical substances subject to this proposed rule 
have undergone premanufacture review. In cases where EPA has not 
received a notice of commencement (NOC) and the chemical substance has 
not been added to the TSCA Inventory, no person may commence such 
activities without first submitting a PMN. Therefore, for chemical 
substances for which an NOC has not been submitted EPA concludes that 
the designated significant new uses are not ongoing.
    When chemical substances identified in this proposed rule are added 
to the TSCA Inventory, EPA recognizes that, before the rule is 
effective, other persons might engage in a use that has been identified 
as a significant new use. However, TSCA Orders have been issued for 42 
of the 45 chemical substances that are the subject of this proposed 
SNUR, and the PMN submitters are prohibited by the TSCA Orders from 
undertaking activities which would be designated as significant new 
uses. The identities of all of the chemical substances subject to this 
proposed rule have been claimed as confidential per 40 CFR 720.85. 
Based on this, the Agency believes that it is highly unlikely that any 
of the significant new uses described in the regulatory text of this 
proposed rule are ongoing.
    Therefore, EPA designates October 9, 2020 as the cutoff date for 
determining whether the new use is ongoing. The objective of EPA's 
approach is to ensure that a person cannot defeat a SNUR by initiating 
a significant new use before the effective date of the final rule.
    In the unlikely event that a person began commercial manufacture or 
processing of the chemical substances for a significant new use 
identified as of that date would have to cease any such activity upon 
the effective date of the final rule. To resume their activities, these 
persons would have to first comply with all applicable SNUR 
notification requirements and wait until EPA has conducted a review of 
the notice, made an appropriate determination on the notice, and has 
taken such actions as are required with that determination.
    Issuance of a SNUR for a chemical substance does not signify that 
the chemical substance is listed on the TSCA Chemical Substance 
Inventory (TSCA Inventory). Guidance on how to determine if a chemical 
substance is on the TSCA Inventory is available on the internet at 
https://www.epa.gov/tsca-inventory.

VII. Development and Submission of Information

    EPA recognizes that TSCA section 5 does not require developing any 
particular new information (e.g., generating test data) before 
submission of a SNUN. There is an exception: If a person is required to 
submit information for a chemical substance pursuant to a rule, TSCA 
Order or consent agreement under TSCA section 4, then TSCA section 
5(b)(1)(A) requires such information to be submitted to EPA at the time 
of submission of the SNUN.
    In the absence of a rule, TSCA Order, or consent agreement under 
TSCA section 4 covering the chemical substance, persons are required 
only to submit information in their possession or control and to 
describe any other information known or reasonably ascertainable (40 
CFR 720.50). However, upon review of PMNs and SNUNs, the Agency has the 
authority to require appropriate testing. Unit IV. lists potentially 
useful information for all SNURs listed here. Descriptions of this 
information is provided for informational purposes. The potentially 
useful information identified in Unit IV. of the proposed rule will be 
useful to EPA's evaluation in the event that someone submits a SNUN for 
the significant new use. Companies who are considering submitting a 
SNUN are encouraged, but not required, to develop the information on 
the substance, which may assist with EPA's analysis of the SNUN. EPA 
strongly encourages persons, before performing any testing, to consult 
with the Agency. Furthermore, pursuant to TSCA section 4(h), which 
pertains to reduction of testing on vertebrate animals, EPA encourages 
dialog with the Agency on the use of alternative test methods and 
strategies (also called New Approach Methodologies, or NAMs), if 
available, to generate the potentially useful information. EPA 
encourages dialogue with Agency representatives to help determine how 
best the submitter can meet both the data needs and the objective of 
TSCA section 4(h). To access the OCSPP test guidelines referenced in 
this document electronically, please go to http://www.epa.gov/ocspp and 
select ``Test Methods and Guidelines.'' The Organisation for Economic 
Co-operation and Development (OECD) test guidelines are available from 
the OECD Bookshop at http://www.oecdbookshop.org or SourceOECD at 
http://www.sourceoecd.org.
    The potentially useful information listed in Unit IV. may not be 
the only means of addressing the potential risks of the chemical 
substance. However, submitting a SNUN without any test data or other 
information may increase the likelihood that EPA will take action under 
TSCA section 5(e) or 5(f). EPA recommends that potential SNUN 
submitters contact EPA early enough so that they will be able to 
conduct the appropriate tests.
    SNUN submitters should be aware that EPA will be better able to 
evaluate SNUNs which provide detailed information on the following:

[[Page 64287]]

     Human exposure and environmental release that may result 
from the significant new use of the chemical substances.
     Information on risks posed by the chemical substances 
compared to risks posed by potential substitutes.

VIII. SNUN Submissions

    According to 40 CFR 721.1(c), persons submitting a SNUN must comply 
with the same notification requirements and EPA regulatory procedures 
as persons submitting a PMN, including submission of test data on 
health and environmental effects as described in 40 CFR 720.50. SNUNs 
must be submitted on EPA Form No. 7710-25, generated using e-PMN 
software, and submitted to the Agency in accordance with the procedures 
set forth in 40 CFR 720.40. E-PMN software is available electronically 
at https://www.epa.gov/reviewing-new-chemicals-under-toxic-substances-control-act-tsca.

IX. Economic Analysis

    EPA has evaluated the potential costs of establishing SNUN 
requirements for potential manufacturers and processors of the chemical 
substances subject to this proposed rule. EPA's complete economic 
analysis is available in the docket under docket ID number EPA-HQ-OPPT-
2020-0131.

X. Statutory and Executive Order Reviews

    Additional information about these statutes and Executive Orders 
can be found at https://www.epa.gov/laws-regulations-and-executive-orders.

A. Executive Order 12866: Regulatory Planning and Review and Executive 
Order 13563: Improving Regulations and Regulatory Review

    This proposed rule would establish SNURs for several new chemical 
substances that were the subject of PMNs. The Office of Management and 
Budget (OMB) has exempted these types of actions from review under 
Executive Orders 12866 (58 FR 51735, October 4, 1993) and 13563 (76 FR 
3821, January 21, 2011).

B. Paperwork Reduction Act (PRA)

    According to the PRA (44 U.S.C. 3501 et seq.), an agency may not 
conduct or sponsor, and a person is not required to respond to a 
collection of information that requires OMB approval under PRA, unless 
it has been approved by OMB and displays a currently valid OMB control 
number. The OMB control numbers for EPA's regulations in title 40 of 
the CFR, after appearing in the Federal Register, are listed in 40 CFR 
part 9, and included on the related collection instrument or form, if 
applicable.
    The information collection activities related to this action have 
already been approved by OMB under the PRA under OMB control number 
2070-0012 (EPA ICR No. 574). This proposed rule does not contain any 
burden requiring additional OMB approval. If an entity were to submit a 
SNUN to the Agency, the annual burden is estimated to average between 
30 and 170 hours per response. This burden estimate includes the time 
needed to review instructions, search existing data sources, gather and 
maintain the data needed, and complete, review, and submit the required 
SNUN.
    Send any comments about the accuracy of the burden estimate, and 
any suggested methods for minimizing respondent burden, including using 
automated collection techniques, to the Director, Regulatory Support 
Division, Office of Mission Support (2822T), Environmental Protection 
Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-0001. Please 
remember to include the OMB control number in any correspondence, but 
do not submit any completed forms to this address.

C. Regulatory Flexibility Act (RFA)

    Pursuant to the RFA section 605(b) (5 U.S.C. 601 et seq.), the 
Agency hereby certifies that promulgation of these SNURs would not have 
a significant adverse economic impact on a substantial number of small 
entities. The requirement to submit a SNUN applies to any person 
(including small or large entities) who intends to engage in any 
activity described in the final rule as a ``significant new use.'' 
Because these uses are ``new,'' based on all information currently 
available to EPA, it appears that no small or large entities presently 
engage in such activities. A SNUR requires that any person who intends 
to engage in such activity in the future must first notify EPA by 
submitting a SNUN. EPA's experience to date is that, in response to the 
promulgation of SNURs covering over 1,000 chemicals, the Agency 
receives only a small number of notices per year. For example, the 
number of SNUNs received was seven in Federal fiscal year (FY) 2013, 13 
in FY2014, six in FY2015, 10 in FY2016, 14 in FY2017, and 18 in FY2018 
and only a fraction of these were from small businesses. In addition, 
the Agency currently offers relief to qualifying small businesses by 
reducing the SNUN submission fee from $16,000 to $2,800. This lower fee 
reduces the total reporting and recordkeeping of cost of submitting a 
SNUN to about $10,116 for qualifying small firms. Therefore, the 
potential economic impacts of complying with this proposed SNUR are not 
expected to be significant or adversely impact a substantial number of 
small entities. In a SNUR that published in the Federal Register of 
June 2, 1997 (62 FR 29684) (FRL-5597-1), the Agency presented its 
general determination that final SNURs are not expected to have a 
significant economic impact on a substantial number of small entities, 
which was provided to the Chief Counsel for Advocacy of the Small 
Business Administration.

D. Unfunded Mandates Reform Act (UMRA)

    Based on EPA's experience with proposing and finalizing SNURs, 
State, local, and Tribal governments have not been impacted by these 
rulemakings, and EPA does not have any reasons to believe that any 
State, local, or Tribal government will be impacted by this action. As 
such, EPA has determined that this proposed rule would not impose any 
enforceable duty, contain any unfunded mandate, or otherwise have any 
effect on small governments subject to the requirements of UMRA 
sections 202, 203, 204, or 205 (2 U.S.C. 1501 et seq.).

E. Executive Order 13132: Federalism

    This action would not have a substantial direct effect on States, 
on the relationship between the national government and the States, or 
on the distribution of power and responsibilities among the various 
levels of government, as specified in Executive Order 13132 (64 FR 
43255, August 10, 1999).

F. Executive Order 13175: Consultation and Coordination With Indian 
Tribal Governments

    This action would not have Tribal implications because it is not 
expected to have substantial direct effects on Indian Tribes. This 
action would not significantly nor uniquely affect the communities of 
Indian Tribal governments, nor would it involve or impose any 
requirements that affect Indian Tribes. Accordingly, the requirements 
of Executive Order 13175 (65 FR 67249, November 9, 2000), do not apply 
to this action.

G. Executive Order 13045: Protection of Children From Environmental 
Health Risks and Safety Risks

    This proposed rule is not subject to Executive Order 13045 (62 FR 
19885, April 23, 1997), because this is not an economically significant 
regulatory

[[Page 64288]]

action as defined by Executive Order 12866, and this action does not 
address environmental health or safety risks disproportionately 
affecting children.

H. Executive Order 13211: Actions Concerning Regulations That 
Significantly Affect Energy Supply, Distribution, or Use

    This proposed rule is not subject to Executive Order 13211 (66 FR 
28355, May 22, 2001), because this proposed rule is not expected to 
affect energy supply, distribution, or use.

I. National Technology Transfer and Advancement Act (NTTAA)

    This action does not involve any technical standards subject to 
NTTAA section 12(d) (15 U.S.C. 272 note).

J. Executive Order 12898: Federal Actions To Address Environmental 
Justice in Minority Populations and Low-Income Populations

    This action does not entail special considerations of environmental 
justice related issues as delineated by Executive Order 12898 (59 FR 
7629, February 16, 1994).

List of Subjects in 40 CFR Part 721

    Environmental protection, Chemicals, Hazardous substances, 
Reporting and recordkeeping requirements.

    Dated: September 14, 2020.
Tala Henry,
Deputy Director, Office of Pollution Prevention and Toxics.

    Therefore, for the reasons stated in the preamble, it is proposed 
that 40 CFR chapter I be amended as follows:

PARTS 721--SIGNIFICANT NEW USES OF CHEMICAL SUBSTANCES

0
1. The authority citation for part 721 continues to read as follows:

    Authority: 15 U.S.C. 2604, 2607, 2613, and 2625(c).

0
2. Add Sec. Sec.  721.11401 through 721.11403 and Sec. Sec.  721.11514 
through 721.11555 to subpart E to read as follows:

Subpart E--Significant New Uses for Specific Chemical Substances

* * * * *
Sec.
* * * * *
721.11401 2-Propenoic acid, 2-methyl-, methyl ester, polymer with 
ethenylbenzene, ethyl 2-propenoate, 2-oxiranylmethyl 2-methyl-2-
propenoate and 1,2-propanediol mono(2-methyl-2-propenoate), reaction 
products with diethanolamine, polymers with substituted-alkyl 
acrylate, formats (salts) (generic).
721.11402 2-Propenoic acid, 2-methyl, methyl ester, polymer with 
ethenylbenzene, ethyl 2-propenoate, 2-oxiranylmethyl 2-methyl-2-
propenoate and 1,2-propanediol mono(2-methyl-2-propenoate), reaction 
products with diethanolamine, polymers with substituted-alkyl 
methacrylate, formats (salts) (generic).
721.11403 2-Propenoic acid, 2-methyl-, methyl ester, polymer with 
ethenylbenzene, ethyl 2-propenoate, 2-oxrianylmethyl 2-methyl-2-
propenoate, and 1,2-propaneidol mono(2-methyl-2-propenoate), 
reaction products with diethanolamine, polymers with alkylene glycol 
monoacrylate, formats (salts) (generic).
* * * * *
721.11514 Organic sulfonate compound (generic).
721.11515 Thiophenium, 1-(2,7-disubstituted-1-
naphthalenyl)tetrahydro-, salt with polyfluoro-N-
polyfluoroalkylsulfonyl-1-alkanesulfonamide (1:1) (generic).
721.11516 Sulfonium, triphenyl-, salt with 2,3-bis(substituted) 5-
sulfocarbopolycyclic-2,3-carboxylate derivative (1:1) (generic).
721.11517 Thiophenium, 1-(2,7-disubstituted-1-
naphthalenyl)tetrahydro-, salt with polyfluoro-N-
polyfluoroalkylsulfonyl-1-alkanesulfonamide (1:1) (generic).
721.11518 Sulfonium, triphenyl-, 5-(alkyl) fluoropentane derivative 
(generic).
721.11519 Sulfonium, triphenyl-, salt with substituted-alkyl 4-
substituted-benzoate (generic).
721.11520 Substituted-triphenylsulfonium, inner salt (generic).
721.11521 Sulfonium, triphenyl-, salt with disubstituted-
heterocyclic compound (1:1) (generic).
721.11522 Sulfonium, triphenyl-, salt with 2,4,5-trisubstituted-
benzenesulfonate (1:1) (generic).
721.11523 Substituted heterocyclic onium compound, salt with 2,2,2-
trifluoro-1-(sulfomethyl)-1-(trifluoromethyl)ethyl 3-[(2-methyl-1-
oxo-2-propen-1-yl)oxy]tricyclo[3.3.1.13,7]decane-1-carboxylate 
(1:1), polymer with acenaphthylene, 1-ethenyl-4-[(1-
ethylcyclopentyl)oxy]benzene and 4-ethenylphenol, di-Me 2,2'-(1,2-
diazenediyl)bis[2-methylpropanoate]-initiated (generic).
721.11524 Substituted heterocyclic onium compound, salt with 2,2,2-
trifluoro-1-(sulfomethyl)-1-(trifluoromethyl)ethyl 3-[(2-methyl-1-
oxo-2-propen-1-yl)oxy]tricyclo[3.3.1.13,7]decane-1-carboxylate 
(1:1), polymer with acenaphthylene 1-ethenyl-4-[[1-(1-
methylethyl)cyclopentyl]oxy]benzene and 4-ethenylphenol, di-Me 2,2'-
(1,2-diazenediyl)bis[2-methylpropanoate]-initiated (generic).
721.11525 Dibenzothiophenium, aryl substituted trifluoro-hydroxy-
(triheterosubstitutedalkyl)alkanoate (1:1) (generic).
721.11526 Substituted heterocyclic onium compound, salt with 1-
(difluorosulfomethyl)-2,2,2-trifluoroethyl 3-[(2-methyl-1-oxo-2-
propen-1-yl)oxy]tricyclo[3.3.1.13,7]decane-1-carboxylate (1:1), 
polymer with 3-ethenylphenol, 1-(1-methylethyl)cyclopentyl 2-methyl-
2-propenoate and 1-(7-oxabicyclo[2.2.1]hept-2-yl)cyclopentyl 2-
methyl-2-propenoate, di-Me 2,2'-(1,2-diazenediyl)bis[2-
methylpropenoate]-initiated (generic).
721.11527 Sulfonium, triphenyl-, trifluoro-hydroxy-
(triheterosubstitutedalkyl)alkanoate (1:1) (generic).
721.11528 Heterotrisubstituted-bile acid, 1-(difluorosulfomethyl)-
2,2,2-trifluoroethyl ester, ion(1-), (5)-, triphenylsulfonium (1:1) 
(generic).
721.11529 Aromatic sulfonium tricyclo fluoroalkyl sulfonic acid salt 
(generic)
721.11530 Substituted, (alkylaromatic)diaromatic salt with trihalo-
[(trihaloalkyl)substituted]substituted alkaneamide (generic).
721.11531 Triarylsulfonium substituted oxatricycloalkyloxycarbonyl 
dihalo alkane sulfonate (generic).
721.11532 Substituted triarylsulfonium carbopolycyclic 
heteromonocyclic dihalo sulfoacetate (generic).
721.11533 Substituted triarylsulfonium substituted carbopolycyclic 
carboxylate (generic).
721.11534 Sulfonium, bis(dihalocarbomonocycle) carbomonocycle, salt 
with substituted heteropolycycle dihalo sulfoalkanoate (1:1) 
(generic).
721.11535 Heteropolycycle, alkylaromatic-, salt with dihalo-
substituted alkyl carbopolycycle carboxylate (generic).
721.11536 Sulfonium, triaryl-, salt with polyhalo-4-sulfoalkyl 
polycarbocyclic alkane-1-carboxylate (1:1) (generic).
721.11537 Sulfonium, bis(dihalocarbomonocycle) carbomonocycle, salt 
with dihalo substituted alkyl carbopolycyclic carboxylate (1:1) 
(generic).
721.11538 Sulfonium, bis(dihalocarbomonocycle) carbomonocycle, 
substituted carbomonocyclic ester (generic).
721.11539 Heteropolycycle, aromatic-, salt with dihalo-substituted 
alkyl carbopolycycle carboxylate (1:1) (generic).
721.11540 Triarylsulfonium alkylestersulfonate (generic).
721.11541 Halogenated alkylbenzoic acid (generic).
721.11542 Halogenated alkylbenzoic acid (generic).
721.11543 Halogenated benzoic acid (generic).
721.11544 Halogenated benzoic acid (generic).
721.11545 Halogenated benzoic acid (generic).
721.11546 Halogenated alkylbenzoic acid (generic).
721.11547 Halogenated alkylbenzoic acid (generic).
721.11548 Halogenated alkylbenzoic acid (generic).

[[Page 64289]]

721.11549 Halogenated alkylbenzoic acid (generic).
721.11550 Halogenated alkylbenzoic acid (generic).
721.11551 Halogenated sodium benzoate (generic).
721.11552 Halogenated sodium benzoate (generic).
721.11553 Halogenated sodium benzoate (generic).
721.11554 Halogenated sodium alkylbenzoate (generic).
721.11555 Halogenated sodium alkylbenzoate (generic).
* * * * *

Sec.  721.11401   2-Propenoic acid, 2-methyl-, methyl ester, polymer 
with ethenylbenzene, ethyl 2-propenoate, 2-oxiranylmethyl 2-methyl-2-
propenoate and 1,2-propanediol mono(2-methyl-2-propenoate), reaction 
products with diethanolamine, polymers with substituted-alkyl acrylate, 
formats (salts) (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 2-
propenoic acid, 2-methyl-, methyl ester, polymer with ethenylbenzene, 
ethyl 2-propenoate, 2-oxiranylmethyl 2-methyl-2-propenoate and 1,2-
propanediol mono(2-methyl-2-propenoate), reaction products with 
diethanolamine, polymers with substituted-alkyl acrylate, formats 
(salts) (PMN P-18-241) is subject to reporting under this section for 
the significant new uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(j).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (c), and (i) are applicable to manufacturers and 
processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(i) of 
this section.

Sec.  721.11402   2-Propenoic acid, 2-methyl, methyl ester, polymer 
with ethenylbenzene, ethyl 2-propenoate, 2-oxiranylmethyl 2-methyl-2-
propenoate and 1,2-propanediol mono(2-methyl-2-propenoate), reaction 
products with diethanolamine, polymers with substituted-alkyl 
methacrylate, formats (salts) (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 2-
propenoic acid, 2-methyl, methyl ester, polymer with ethenylbenzene, 
ethyl 2-propenoate, 2-oxiranylmethyl 2-methyl-2-propenoate and 1,2-
propanediol mono(2-methyl-2-propenoate), reaction products with 
diethanolamine, polymers with substituted-alkyl methacrylate, formats 
(salts) (PMN P-18-244) is subject to reporting under this section for 
the significant new uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(j).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (c), and (i) are applicable to manufacturers and 
processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(i) of 
this section.

Sec.  721.11403   2-Propenoic acid, 2-methyl-, methyl ester, polymer 
with ethenylbenzene, ethyl 2-propenoate, 2-oxrianylmethyl 2-methyl-2-
propenoate, and 1,2-propaneidol mono(2-methyl-2-propenoate), reaction 
products with diethanolamine, polymers with alkylene glycol 
monoacrylate, formats (salts) (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 2-
propenoic acid, 2-methyl-, methyl ester, polymer with ethenylbenzene, 
ethyl 2-propenoate, 2-oxrianylmethyl 2-methyl-2-propenoate, and 1,2-
propaneidol mono(2-methyl-2-propenoate), reaction products with 
diethanolamine, polymers with alkylene glycol monoacrylate, formats 
(salts) (PMN P-18-245) is subject to reporting under this section for 
the significant new uses described in paragraph (a)(2) of this section.
    (2) The significant new uses are:
    (i) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(j).
    (ii) [Reserved]
    (b) Specific requirements. The provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (c), and (i) are applicable to manufacturers and 
processors of these substances.
    (2) Limitations or revocation of certain notification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(i) of 
this section.
* * * * *

Sec.  721.11514   Organic sulfonate compound (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as organic 
sulfonate compound (PMN P-16-539) is subject to reporting under this 
section for the significant new uses described in paragraph (a)(2) of 
this section. The requirements of this section do not apply to 
quantities of the PMN substance after they have been completely reacted 
or adhered (during the photolithographic process) onto a semiconductor 
water surface or similar manufactured article used in the production of 
semiconductor technologies.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer use. Requirements as 
specified in Sec.  721.80(f), (k), and (t). It is a significant new use 
to import the PMN substance other than in solution, unless in sealed 
containers weighing 5 kilograms or less. It is a significant new use to 
process the PMN substance in any way that generates a dust, mist, or 
aerosol in a non-enclosed process. It is

[[Page 64290]]

a significant new use to manufacture the PMN substance longer than 18 
months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11515  Thiophenium, 1-(2,7-disubstituted-1-
naphthalenyl)tetrahydro-, salt with polyfluoro-N-
polyfluoroalkylsulfonyl-1-alkanesulfonamide (1:1) (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
thiophenium, 1-(2,7-disubstituted-1-naphthalenyl)tetrahydro-, salt with 
polyfluoro-N-polyfluoroalkylsulfonyl-1-alkanesulfonamide (1:1) (PMN P-
18-157) is subject to reporting under this section for the significant 
new uses described in paragraph (a)(2) of this section. The 
requirements of this section do not apply to quantities of the PMN 
substance after they have been completely reacted or adhered (during 
the photolithographic process) onto a semiconductor water surface or 
similar manufactured article used in the production of semiconductor 
technologies.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer use. Requirements as 
specified in Sec.  721.80(f), (k), and (t). It is a significant new use 
to import the PMN substance other than in solution, unless in sealed 
containers weighing 5 kilograms or less. It is a significant new use to 
process the PMN substance in any way that generates a dust, mist, or 
aerosol in a non-enclosed process. It is a significant new use to 
manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11516  Sulfonium, triphenyl-, salt with 2,3-bis(substituted) 
5-sulfocarbopolycyclic-2,3-carboxylate derivative (1:1) (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
sulfonium, triphenyl-, salt with 2,3-bis(substituted) 5-
sulfocarbopolycyclic-2,3-carboxylate derivative (1:1) (PMN P-18-158), 
is subject to reporting under this section for the significant new uses 
described in paragraph (a)(2) of this section. The requirements of this 
section do not apply to quantities of the PMN substance after they have 
been completely reacted or adhered (during the photolithographic 
process) onto a semiconductor water surface or similar manufactured 
article used in the production of semiconductor technologies.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer use. Requirements as 
specified in Sec.  721.80(f), (k), and (t). It is a significant new use 
to import the PMN substance other than in solution, unless in sealed 
containers weighing 5 kilograms or less. It is a significant new use to 
process the PMN substance in any way that generates a dust, mist, or 
aerosol in a non-enclosed process. It is a significant new use to 
manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11517  Thiophenium, 1-(2,7-disubstituted-1-
naphthalenyl)tetrahydro-, salt with polyfluoro-N-
polyfluoroalkylsulfonyl-1-alkanesulfonamide (1:1) (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
thiophenium, 1-(2,7-disubstituted-1-naphthalenyl)tetrahydro-, salt with 
polyfluoro-N-polyfluoroalkylsulfonyl-1-alkanesulfonamide (1:1) (PMN P-
18-159) is subject to reporting under this section for the significant 
new uses described in paragraph (a)(2) of this section. The 
requirements of this section do not apply to quantities of the PMN 
substance after they have been completely reacted or adhered (during 
the photolithographic process) onto a semiconductor water surface or 
similar manufactured article used in the production of semiconductor 
technologies.
    (2) The significant new uses are:

[[Page 64291]]

    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer use. Requirements as 
specified in Sec.  721.80(f), (k), and (t). It is a significant new use 
to import the PMN substance other than in solution, unless in sealed 
containers weighing 5 kilograms or less. It is a significant new use to 
process the PMN substance in any way that generates a dust, mist, or 
aerosol in a non-enclosed process. It is a significant new use to 
manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11518   Sulfonium, triphenyl-, 5-(alkyl) fluoropentane 
derivative (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
sulfonium, triphenyl-, 5-(alkyl) fluoropentane derivative (PMN P-19-33) 
is subject to reporting under this section for the significant new uses 
described in paragraph (a)(2) of this section. The requirements of this 
section do not apply to quantities of the PMN substance after they have 
been completely reacted or adhered (during the photolithographic 
process) onto a semiconductor water surface or similar manufactured 
article used in the production of semiconductor technologies.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer use. Requirements as 
specified in Sec.  721.80(f), (k), and (t). It is a significant new use 
to import the PMN substance other than in solution, unless in sealed 
containers weighing 5 kilograms or less. It is a significant new use to 
process the PMN substance in any way that generates a dust, mist, or 
aerosol in a non-enclosed process. It is a significant new use to 
manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11519   Sulfonium, triphenyl-, salt with substituted-alkyl 4-
substituted-benzoate (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
sulfonium, triphenyl-, salt with substituted-alkyl 4-substituted-
benzoate (PMN P-17-178) is subject to reporting under this section for 
the significant new use described in paragraph (a)(2) of this section. 
The requirements of this section do not apply to quantities of the 
substance after they have been completely reacted or adhered (during 
the photolithographic process) onto a semiconductor water surface or 
similar manufactured article used in the production of semiconductor 
technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), and (e), (g)(1)(i), (2)(i) through (iii), and 
(v), (3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions

[[Page 64292]]

of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section.

Sec.  721.11520  Substituted-triphenylsulfonium, inner salt (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
substituted-triphenylsulfonium, inner salt (PMN P-18-13) is subject to 
reporting under this section for the significant new use described in 
paragraph (a)(2) of this section. The requirements of this section do 
not apply to quantities of the substance after they have been 
completely reacted or adhered (during the photolithographic process) 
onto a semiconductor water surface or similar manufactured article used 
in the production of semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11521   Sulfonium, triphenyl-, salt with disubstituted-
heterocyclic compound (1:1) (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
sulfonium, triphenyl-, salt with disubstituted-heterocyclic compound 
(1:1) (PMN P-18-14) is subject to reporting under this section for the 
significant new use described in paragraph (a)(2) of this section. The 
requirements of this section do not apply to quantities of the 
substance after they have been completely reacted or adhered (during 
the photolithographic process) onto a semiconductor water surface or 
similar manufactured article used in the production of semiconductor 
technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11522  Sulfonium, triphenyl-, salt with 2,4,5-trisubstituted-
benzenesulfonate (1:1) (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
sulfonium, triphenyl-, salt with 2,4,5-trisubstituted-benzenesulfonate 
(1:1) (PMN P-18-37) is subject to reporting under this section for the 
significant new use described in paragraph (a)(2) of this section. The 
requirements of this section do not apply to quantities of the 
substance after they have been completely reacted or adhered (during 
the photolithographic process) onto a semiconductor water surface or 
similar manufactured article used in the production of semiconductor 
technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as

[[Page 64293]]

specified in Sec.  721.80(f), (k), and (t). It is a significant new use 
to import the PMN substance other than in solution, unless in sealed 
containers weighing 5 kilograms or less. It is a significant new use to 
process the PMN substance in any way that generates a dust, mist, or 
aerosol in a non-enclosed process. It is a significant new use to 
manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11523   Substituted heterocyclic onium compound, salt with 
2,2,2-trifluoro-1-(sulfomethyl)-1-(trifluoromethyl)ethyl 3-[(2-methyl-
1-oxo-2-propen-1-yl)oxy]tricyclo[3.3.1.13,7]decane-1-carboxylate (1:1), 
polymer with acenaphthylene, 1-ethenyl-4-[(1-
ethylcyclopentyl)oxy]benzene and 4-ethenylphenol, di-Me 2,2'-(1,2-
diazenediyl)bis[2-methylpropanoate]-initiated (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
substituted heterocyclic onium compound, salt with 2,2,2-trifluoro-1-
(sulfomethyl)-1-(trifluoromethyl)ethyl 3-[(2-methyl-1-oxo-2-propen-1-
yl)oxy]tricyclo[3.3.1.13,7]decane-1-carboxylate (1:1), polymer with 
acenaphthylene, 1-ethenyl-4-[(1-ethylcyclopentyl)oxy]benzene and 4-
ethenylphenol, di-Me 2,2'-(1,2-diazenediyl)bis[2-methylpropanoate]-
initiated (PMN P-19-78) is subject to reporting under this section for 
the significant new use described in paragraph (a)(2) of this section. 
The requirements of this section do not apply to quantities of the 
substance after they have been completely reacted or adhered (during 
the photolithographic process) onto a semiconductor water surface or 
similar manufactured article used in the production of semiconductor 
technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11524   Substituted heterocyclic onium compound, salt with 
2,2,2-trifluoro-1-(sulfomethyl)-1-(trifluoromethyl)ethyl 3-[(2-methyl-
1-oxo-2-propen-1-yl)oxy]tricyclo[3.3.1.13,7]decane-1-carboxylate (1:1), 
polymer with acenaphthylene 1-ethenyl-4-[[1-(1-
methylethyl)cyclopentyl]oxy]benzene and 4-ethenylphenol, di-Me 2,2'-
(1,2-diazenediyl)bis[2-methylpropanoate]-initiated (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
substituted heterocyclic onium compound, salt with 2,2,2-trifluoro-1-
(sulfomethyl)-1-(trifluoromethyl)ethyl 3-[(2-methyl-1-oxo-2-propen-1-
yl)oxy]tricyclo[3.3.1.13,7]decane-1-carboxylate (1:1), polymer with 
acenaphthylene 1-ethenyl-4-[[1-(1-methylethyl)cyclopentyl]oxy]benzene 
and 4-ethenylphenol, di-Me 2,2'-(1,2-diazenediyl)bis[2-
methylpropanoate]-initiated (PMN P-19-79) is subject to reporting under 
this section for the significant new use described in paragraph (a)(2) 
of this section. The requirements of this section do not apply to 
quantities of the substance after they have been completely reacted or 
adhered (during the photolithographic process) onto a semiconductor 
water surface or similar manufactured article used in the production of 
semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The

[[Page 64294]]

provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11525  Dibenzothiophenium, aryl substituted trifluoro-
hydroxy-(triheterosubstitutedalkyl)alkanoate (1:1) (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
dibenzothiophenium, aryl substituted trifluoro-hydroxy-
(triheterosubstitutedalkyl)alkanoate (1:1) (PMN P-19-111) is subject to 
reporting under this section for the significant new use described in 
paragraph (a)(2) of this section. The requirements of this section do 
not apply to quantities of the substance after they have been 
completely reacted or adhered (during the photolithographic process) 
onto a semiconductor water surface or similar manufactured article used 
in the production of semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11526   Substituted heterocyclic onium compound, salt with 1-
(difluorosulfomethyl)-2,2,2-trifluoroethyl 3-[(2-methyl-1-oxo-2-propen-
1-yl)oxy]tricyclo[3.3.1.13,7]decane-1-carboxylate (1:1), polymer with 
3-ethenylphenol, 1-(1-methylethyl)cyclopentyl 2-methyl-2-propenoate and 
1-(7-oxabicyclo[2.2.1]hept-2-yl)cyclopentyl 2-methyl-2-propenoate, di-
Me 2,2'-(1,2-diazenediyl)bis[2-methylpropenoate]-initiated (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
substituted heterocyclic onium compound, salt with 1-
(difluorosulfomethyl)-2,2,2-trifluoroethyl 3-[(2-methyl-1-oxo-2-propen-
1-yl)oxy]tricyclo[3.3.1.13,7]decane-1-carboxylate (1:1), polymer with 
3-ethenylphenol, 1-(1-methylethyl)cyclopentyl 2-methyl-2-propenoate and 
1-(7-oxabicyclo[2.2.1]hept-2-yl)cyclopentyl 2-methyl-2-propenoate, di-
Me 2,2'-(1,2-diazenediyl)bis[2-methylpropenoate]-initiated (PMN P-19-
112) is subject to reporting under this section for the significant new 
use described in paragraph (a)(2) of this section. The requirements of 
this section do not apply to quantities of the substance after they 
have been completely reacted or adhered (during the photolithographic 
process) onto a semiconductor water surface or similar manufactured 
article used in the production of semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11527   Sulfonium, triphenyl-, trifluoro-hydroxy-
(triheterosubstitutedalkyl)alkanoate (1:1) (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
sulfonium, triphenyl-, trifluoro-hydroxy-
(triheterosubstitutedalkyl)alkanoate (1:1) (PMN P-19-114) is subject to 
reporting under this section for the significant new use described in 
paragraph (a)(2) of this section. The requirements of this section do 
not apply to quantities of the substance after they have been 
completely reacted or adhered (during the photolithographic process) 
onto a semiconductor water surface or similar manufactured article used 
in the production of semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in

[[Page 64295]]

Sec.  721.63(a)(1), (2)(i) and (iii), and (3), and (c). When 
determining which persons are reasonably likely to be exposed as 
required for Sec.  721.63(a)(1), engineering control measures (e.g., 
enclosure or confinement of the operation, general and local 
ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent 
exposure, where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11528  Heterotrisubstituted-bile acid, 1-
(difluorosulfomethyl)-2,2,2-trifluoroethyl ester, ion(1-), (5)-, 
triphenylsulfonium (1:1) (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
heterotrisubstituted-bile acid, 1-(difluorosulfomethyl)-2,2,2-
trifluoroethyl ester, ion(1-), (5)-, triphenylsulfonium (1:1) (PMN P-
19-133) is subject to reporting under this section for the significant 
new use described in paragraph (a)(2) of this section. The requirements 
of this section do not apply to quantities of the substance after they 
have been completely reacted or adhered (during the photolithographic 
process) onto a semiconductor water surface or similar manufactured 
article used in the production of semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11529  Aromatic sulfonium tricyclo fluoroalkyl sulfonic acid 
salt (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
aromatic sulfonium tricyclo fluoroalkyl sulfonic acid salt (PMN P-18-
16) is subject to reporting under this section for the significant new 
uses described in paragraph (a)(2) of this section. The requirements of 
this section do not apply to quantities of the PMN substance after they 
have been completely reacted or adhered (during the photolithographic 
process) onto a semiconductor water surface or similar manufactured 
article used in the production of semiconductor technologies.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to use or process the PMN substance in any way that generates a 
dust, mist, or aerosol in a non-enclosed process. It is a significant 
new use to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.

[[Page 64296]]

    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11530   Substituted, (alkylaromatic)diaromatic salt with 
trihalo-[(trihaloalkyl)substituted]substituted alkaneamide (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
substituted, (alkylaromatic)diaromatic salt with trihalo-
[(trihaloalkyl)substituted]substituted alkaneamide (PMN P-18-297) is 
subject to reporting under this section for the significant new use 
described in paragraph (a)(2) of this section. The requirements of this 
section do not apply to quantities of the substance after they have 
been completely reacted or adhered (during the photolithographic 
process) onto a semiconductor water surface or similar manufactured 
article used in the production of semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11531  Triarylsulfonium substituted 
oxatricycloalkyloxycarbonyl dihalo alkane sulfonate (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
triarylsulfonium substituted oxatricycloalkyloxycarbonyl dihalo alkane 
sulfonate (PMN P-18-311) is subject to reporting under this section for 
the significant new use described in paragraph (a)(2) of this section. 
The requirements of this section do not apply to quantities of the 
substance after they have been completely reacted or adhered (during 
the photolithographic process) onto a semiconductor water surface or 
similar manufactured article used in the production of semiconductor 
technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11532  Substituted triarylsulfonium carbopolycyclic 
heteromonocyclic dihalo sulfoacetate (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
substituted triarylsulfonium carbopolycyclic heteromonocyclic dihalo 
sulfoacetate (PMN P-18-314) is subject to reporting under this section 
for the significant new use described in paragraph (a)(2) of this 
section. The requirements of this section do not apply to quantities of 
the substance after they have been completely reacted or adhered 
(during the photolithographic process) onto a semiconductor water 
surface or similar manufactured article used in the production of 
semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin

[[Page 64297]]

sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11533   Substituted triarylsulfonium substituted 
carbopolycyclic carboxylate (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
substituted triarylsulfonium substituted carbopolycyclic carboxylate 
(PMN P-18-315) is subject to reporting under this section for the 
significant new use described in paragraph (a)(2) of this section. The 
requirements of this section do not apply to quantities of the 
substance after they have been completely reacted or adhered (during 
the photolithographic process) onto a semiconductor water surface or 
similar manufactured article used in the production of semiconductor 
technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11534  Sulfonium, bis(dihalocarbomonocycle) carbomonocycle, 
salt with substituted heteropolycycle dihalo sulfoalkanoate (1:1) 
(generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
sulfonium, bis(dihalocarbomonocycle) carbomonocycle, salt with 
substituted heteropolycycle dihalo sulfoalkanoate (1:1) (PMN P-18-304) 
is subject to reporting under this section for the significant new use 
described in paragraph (a)(2) of this section. The requirements of this 
section do not apply to quantities of the substance after they have 
been completely reacted or adhered (during the photolithographic 
process) onto a semiconductor water surface or similar manufactured 
article used in the production of semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11535   Heteropolycycle, alkylaromatic-, salt with dihalo-
substituted alkyl carbopolycycle carboxylate (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified 
heteropolycycle, alkylaromatic-, salt with dihalo-substituted alkyl 
carbopolycycle carboxylate (PMN P-18-316) is subject to reporting under 
this section for the significant new use described in paragraph (a)(2) 
of this section. The requirements of this section do not apply to 
quantities of the substance after

[[Page 64298]]

they have been completely reacted or adhered (during the 
photolithographic process) onto a semiconductor water surface or 
similar manufactured article used in the production of semiconductor 
technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11536   Sulfonium, triaryl-, salt with polyhalo-4-sulfoalkyl 
polycarbocyclic alkane-1-carboxylate (1:1) (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
sulfonium, triaryl-, salt with polyhalo-4-sulfoalkyl polycarbocyclic 
alkane-1-carboxylate (1:1) (PMN P-18-338) is subject to reporting under 
this section for the significant new use described in paragraph (a)(2) 
of this section. The requirements of this section do not apply to 
quantities of the substance after they have been completely reacted or 
adhered (during the photolithographic process) onto a semiconductor 
water surface or similar manufactured article used in the production of 
semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11537  Sulfonium, bis(dihalocarbomonocycle) carbomonocycle, 
salt with dihalo substituted alkyl carbopolycyclic carboxylate (1:1) 
(generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
sulfonium, bis(dihalocarbomonocycle) carbomonocycle, salt with dihalo 
substituted alkyl carbopolycyclic carboxylate (1:1) (PMN P-19-76) is 
subject to reporting under this section for the significant new use 
described in paragraph (a)(2) of this section. The requirements of this 
section do not apply to quantities of the substance after they have 
been completely reacted or adhered (during the photolithographic 
process) onto a semiconductor water surface or similar manufactured 
article used in the production of semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply

[[Page 64299]]

to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11538  Sulfonium, bis(dihalocarbomonocycle) carbomonocycle, 
substituted carbomonocyclic ester (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
sulfonium, bis(dihalocarbomonocycle) carbomonocycle, substituted 
carbomonocyclic ester (PMN P-19-115) is subject to reporting under this 
section for the significant new use described in paragraph (a)(2) of 
this section. The requirements of this section do not apply to 
quantities of the substance after they have been completely reacted or 
adhered (during the photolithographic process) onto a semiconductor 
water surface or similar manufactured article used in the production of 
semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11539  Heteropolycycle, aromatic-, salt with dihalo-
substituted alkyl carbopolycycle carboxylate (1:1) (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
heteropolycycle, aromatic-, salt with dihalo-substituted alkyl 
carbopolycycle carboxylate (1:1) (PMN P-19-142) is subject to reporting 
under this section for the significant new use described in paragraph 
(a)(2) of this section. The requirements of this section do not apply 
to quantities of the substance after they have been completely reacted 
or adhered (during the photolithographic process) onto a semiconductor 
water surface or similar manufactured article used in the production of 
semiconductor technologies.
    (2) The significant new use is:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(f), (k), and (t). It is a significant new 
use to import the PMN substance other than in solution, unless in 
sealed containers weighing 5 kilograms or less. It is a significant new 
use to process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11540  Triarylsulfonium alkylestersulfonate (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
triarylsulfonium alkylestersulfonate (PMN P-19-166) is subject to 
reporting under this section for the significant new uses described in 
paragraph (a)(2) of this section. The requirements of this section do 
not apply to quantities of the PMN substance after they have been 
completely reacted or adhered (during the photolithographic process) 
onto a semiconductor water surface or similar manufactured article used 
in the production of semiconductor technologies.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (3), and (c). When determining 
which persons are reasonably likely to be exposed as required for Sec.  
721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or 
administrative control measures (e.g., workplace policies and 
procedures) shall be considered and implemented to prevent exposure, 
where feasible.

[[Page 64300]]

    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (d), (e), (g)(1)(i), (2)(i) through (iii), and (v), 
(3)(i) and (ii), and (5). For purposes of Sec.  721.72(e), the 
concentration is set at 1.0%. For purposes of Sec.  721.72(g)(1)(i), 
required human health hazard statements include acute toxicity, skin 
sensitization, serious eye damage, specific target organ toxicity, 
neurotoxicity, genetic toxicity, and reproductive toxicity.
    (iii) Industrial, commercial, and consumer use. Requirements as 
specified in Sec.  721.80(f), (k), and (t). It is a significant new use 
to import the PMN substance other than in solution, unless in sealed 
containers weighing 5 kilograms or less. It is a significant new use to 
use or process the PMN substance in any way that generates a dust, 
mist, or aerosol in a non-enclosed process. It is a significant new use 
to manufacture the PMN substance longer than 18 months.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11541  Halogenated alkylbenzoic acid (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
halogenated alkylbenzoic acid (PMN P-19-168) is subject to reporting 
under this section for the significant new use described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (iv), and (3) through (6), (b), and 
(c). When determining which persons are reasonably likely to be exposed 
as required for Sec.  721.63(a)(1) and (a)(4), engineering control 
measures (e.g., enclosure or confinement of the operation, general and 
local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent 
exposure, where feasible. For purposes of Sec.  721.63(a)(5), 
respirators must provide a National Institute for Occupational Safety 
and Health (NIOSH) assigned protection factor (APF) of at least 10. For 
purposes of Sec.  721.63(a)(6), the airborne form(s) of the substance 
include particulate, gas/vapor (all substances in the gas form), 
combination gas/vapor and particulate (gas and liquid/solid physical 
states are present; a good example is paint spray mist, which contains 
both liquid droplets and vapor). For purposes of Sec.  721.63(b), the 
concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph 
(a)(2)(i) of this section, a manufacturer or processor may choose to 
follow the new chemical exposure limit (NCEL) provision listed in the 
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195 
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue 
NCELs as an alternative to Sec.  721.63 respirator requirements may 
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests 
to use the NCELs approach that are approved by EPA will be required to 
follow NCELs provisions comparable to those contained in the 
corresponding TSCA section 5(e) consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix) 
(eye and skin irritation), (g)(2)(i) through (iv), and (v), and (5). 
For purposes of Sec.  721.72(e), the concentration is set at 1.0%. For 
purposes of Sec.  721.72(g)(1)(i), required human health hazard 
statements include acute toxicity, skin sensitization, serious eye 
damage, specific target organ toxicity, neurotoxicity, genetic 
toxicity, and reproductive toxicity. For purposes of Sec.  
721.72(g)(2)(iv), use respiratory protection or maintain workplace 
airborne concentrations at or below an 8-hour time-weighted average of 
0.0195 mg/m\3\. Alternative hazard and warning statements that meet the 
criteria of the Globally Harmonized System and OSHA Hazard 
Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k), (q), and (t). It is a significant new 
use to manufacture or process the PMN substance without including the 
engineering controls/processes described in the TSCA section 5(e) 
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11542  Halogenated alkylbenzoic acid (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
halogenated alkylbenzoic acid (PMN P-19-169) is subject to reporting 
under this section for the significant new use described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (iv), (3) through (6), (b), and 
(c). When determining which persons are reasonably likely to be exposed 
as required for Sec.  721.63(a)(1) and (a)(4), engineering control 
measures (e.g., enclosure or confinement of the operation, general and 
local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent 
exposure, where feasible. For purposes of Sec.  721.63(a)(5), 
respirators must provide a National Institute for Occupational Safety 
and Health (NIOSH) assigned protection factor (APF) of at least 10. For 
purposes of Sec.  721.63(a)(6), the airborne form(s) of the substance 
include particulate, gas/vapor (all substances in the gas form), 
combination gas/vapor and particulate (gas and liquid/solid physical 
states are present; a good example is paint spray mist, which contains 
both liquid droplets and vapor). For purposes of Sec.  721.63(b), the 
concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph 
(a)(2)(i) of this section, a manufacturer or processor may choose to 
follow the new chemical exposure limit (NCEL) provision listed in the 
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195 
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue 
NCELs as an alternative to Sec.  721.63 respirator requirements may 
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests 
to use the NCELs approach that are approved by EPA will be required to 
follow NCELs provisions

[[Page 64301]]

comparable to those contained in the corresponding TSCA section 5(e) 
consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)(eye 
and skin irritation), (g)(2)(i) through (v), and (5). For purposes of 
Sec.  721.72(e), the concentration is set at 1.0%. For purposes of 
Sec.  721.72(g)(1)(i), required human health hazard statements include 
acute toxicity, skin sensitization, serious eye damage, specific target 
organ toxicity, neurotoxicity, genetic toxicity, and reproductive 
toxicity. For purposes of Sec.  721.72(g)(2)(iv), use respiratory 
protection or maintain workplace airborne concentrations at or below an 
8-hour time-weighted average of 0.0195 mg/m\3\. Alternative hazard and 
warning statements that meet the criteria of the Globally Harmonized 
System and OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k), (q), and (t). It is a significant new 
use to manufacture or process the PMN substance without including the 
engineering controls/processes described in the TSCA section 5(e) 
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11543   Halogenated benzoic acid (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
halogenated benzoic acid (PMN P-19-171) is subject to reporting under 
this section for the significant new use described in paragraph (a)(2) 
of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (iv), (3) through (6), and (b), and 
(c). When determining which persons are reasonably likely to be exposed 
as required for Sec.  721.63(a)(1) and (a)(4), engineering control 
measures (e.g., enclosure or confinement of the operation, general and 
local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent 
exposure, where feasible. For purposes of Sec.  721.63(a)(5), 
respirators must provide a National Institute for Occupational Safety 
and Health (NIOSH) assigned protection factor (APF) of at least 10. For 
purposes of Sec.  721.63(a)(6), the airborne form(s) of the substance 
include particulate, gas/vapor (all substances in the gas form), 
combination gas/vapor and particulate (gas and liquid/solid physical 
states are present; a good example is paint spray mist, which contains 
both liquid droplets and vapor). For purposes of Sec.  721.63(b), the 
concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph 
(a)(2)(i) of this section, a manufacturer or processor may choose to 
follow the new chemical exposure limit (NCEL) provision listed in the 
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195 
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue 
NCELs as an alternative to Sec.  721.63 respirator requirements may 
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests 
to use the NCELs approach that are approved by EPA will be required to 
follow NCELs provisions comparable to those contained in the 
corresponding TSCA section 5(e) consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)(eye 
and skin irritation), (g)(2)(i) through (v), and (5). For purposes of 
Sec.  721.72(e), the concentration is set at 1.0%. For purposes of 
Sec.  721.72(g)(1)(i), required human health hazard statements include 
acute toxicity, skin sensitization, serious eye damage, specific target 
organ toxicity, neurotoxicity, genetic toxicity, and reproductive 
toxicity. For purposes of Sec.  721.72(g)(2)(iv), use respiratory 
protection or maintain workplace airborne concentrations at or below an 
8-hour time-weighted average of 0.0195 mg/m\3\. Alternative hazard and 
warning statements that meet the criteria of the Globally Harmonized 
System and OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k), (q), and (t). It is a significant new 
use to manufacture or process the PMN substance without including the 
engineering controls/processes described in the TSCA section 5(e) 
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11544   Halogenated benzoic acid (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
halogenated benzoic acid (PMN P-19-172) is subject to reporting under 
this section for the significant new use described in paragraph (a)(2) 
of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (iv), and (3) through (6), and (b), 
and (c). When determining which persons are reasonably likely to be 
exposed as required for Sec.  721.63(a)(1) and (a)(4), engineering 
control measures (e.g., enclosure or confinement of the operation, 
general and local ventilation) or administrative control measures 
(e.g., workplace policies and procedures) shall be considered and 
implemented to prevent exposure, where feasible. For purposes of Sec.  
721.63(a)(5), respirators must provide a National Institute for 
Occupational Safety and Health (NIOSH) assigned protection factor (APF) 
of at least 10. For purposes of Sec.  721.63(a)(6), the airborne 
form(s) of the substance include particulate, gas/vapor (all substances 
in the gas form), combination gas/vapor and particulate (gas and 
liquid/solid physical states are present; a good example is paint spray 
mist, which contains both liquid droplets and vapor). For purposes of 
Sec.  721.63(b), the concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph 
(a)(2)(i) of this section, a manufacturer or processor may choose to 
follow the new chemical exposure limit (NCEL) provision listed in the 
TSCA section 5(e) consent order

[[Page 64302]]

for this substance. The NCEL is 0.0195 mg/m\3\ as an 8-hour time 
weighted average. Persons who wish to pursue NCELs as an alternative to 
Sec.  721.63 respirator requirements may request to do so under Sec.  
721.30. Persons who Sec.  721.30 requests to use the NCELs approach 
that are approved by EPA will be required to follow NCELs provisions 
comparable to those contained in the corresponding TSCA section 5(e) 
consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), (ix)(eye and 
skin irritation), (g)(2)(i) through (v), and (5). For purposes of Sec.  
721.72(e), the concentration is set at 1.0%. For purposes of Sec.  
721.72(g)(1)(i), required human health hazard statements include acute 
toxicity, skin sensitization, serious eye damage, specific target organ 
toxicity, neurotoxicity, genetic toxicity, and reproductive toxicity. 
For purposes of Sec.  721.72(g)(2)(iv), use respiratory protection or 
maintain workplace airborne concentrations at or below an 8-hour time-
weighted average of 0.0195 mg/m\3\. Alternative hazard and warning 
statements that meet the criteria of the Globally Harmonized System and 
OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k), (q), and (t). It is a significant new 
use to manufacture or process the PMN substance without including the 
engineering controls/processes described in the TSCA section 5(e) 
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11545  Halogenated benzoic acid (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
halogenated benzoic acid (PMN P-19-173) is subject to reporting under 
this section for the significant new use described in paragraph (a)(2) 
of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (iv), and (3) through (6), and (b), 
and (c). When determining which persons are reasonably likely to be 
exposed as required for Sec.  721.63(a)(1) and (a)(4), engineering 
control measures (e.g., enclosure or confinement of the operation, 
general and local ventilation) or administrative control measures 
(e.g., workplace policies and procedures) shall be considered and 
implemented to prevent exposure, where feasible. For purposes of Sec.  
721.63(a)(5), respirators must provide a National Institute for 
Occupational Safety and Health (NIOSH) assigned protection factor (APF) 
of at least 10. For purposes of Sec.  721.63(a)(6), the airborne 
form(s) of the substance include particulate, gas/vapor (all substances 
in the gas form), combination gas/vapor and particulate (gas and 
liquid/solid physical states are present; a good example is paint spray 
mist, which contains both liquid droplets and vapor). For purposes of 
Sec.  721.63(b), the concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph 
(a)(2)(i) of this section, a manufacturer or processor may choose to 
follow the new chemical exposure limit (NCEL) provision listed in the 
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195 
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue 
NCELs as an alternative to Sec.  721.63 respirator requirements may 
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests 
to use the NCELs approach that are approved by EPA will be required to 
follow NCELs provisions comparable to those contained in the 
corresponding TSCA section 5(e) consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix)(eye 
and skin irritation), (g)(2)(i) through (v), and (5). For purposes of 
Sec.  721.72(e), the concentration is set at 1.0%. For purposes of 
Sec.  721.72(g)(1)(i), required human health hazard statements include 
acute toxicity, skin sensitization, serious eye damage, specific target 
organ toxicity, neurotoxicity, genetic toxicity, and reproductive 
toxicity. For purposes of Sec.  721.72(g)(2)(iv), use respiratory 
protection or maintain workplace airborne concentrations at or below an 
8-hour time-weighted average of 0.0195 mg/m\3\. Alternative hazard and 
warning statements that meet the criteria of the Globally Harmonized 
System and OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k), (q), and (t). It is a significant new 
use to manufacture or process the PMN substance without including the 
engineering controls/processes described in the TSCA section 5(e) 
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11546  Halogenated alkylbenzoic acid (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
halogenated alkylbenzoic acid (PMN P-19-175) is subject to reporting 
under this section for the significant new use described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (iv), and (3) through (6), and (b), 
and (c). When determining which persons are reasonably likely to be 
exposed as required for Sec.  721.63(a)(1) and (a)(4), engineering 
control measures (e.g., enclosure or confinement of the operation, 
general and local ventilation) or administrative control measures 
(e.g., workplace policies and procedures) shall be considered and 
implemented to prevent exposure, where feasible. For purposes of Sec.  
721.63(a)(5), respirators must provide a National Institute for 
Occupational Safety and Health (NIOSH) assigned protection factor (APF) 
of at least 10. For purposes of Sec.  721.63(a)(6), the airborne 
form(s) of the substance include particulate, gas/vapor (all substances 
in the gas form), combination gas/vapor and particulate (gas and 
liquid/solid physical states are present; a good example is paint spray 
mist, which contains both liquid droplets and vapor). For purposes of

[[Page 64303]]

Sec.  721.63(b), the concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph 
(a)(2)(i) of this section, a manufacturer or processor may choose to 
follow the new chemical exposure limit (NCEL) provision listed in the 
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195 
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue 
NCELs as an alternative to Sec.  721.63 respirator requirements may 
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests 
to use the NCELs approach that are approved by EPA will be required to 
follow NCELs provisions comparable to those contained in the 
corresponding TSCA section 5(e) consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix) 
(eye and skin irritation), (g)(2)(i) through (v), and (5). For purposes 
of Sec.  721.72(e), the concentration is set at 1.0%. For purposes of 
Sec.  721.72(g)(1)(i), required human health hazard statements include 
acute toxicity, skin sensitization, serious eye damage, specific target 
organ toxicity, neurotoxicity, genetic toxicity, and reproductive 
toxicity. For purposes of Sec.  721.72(g)(2)(iv), use respiratory 
protection or maintain workplace airborne concentrations at or below an 
8-hour time-weighted average of 0.0195 mg/m\3\. Alternative hazard and 
warning statements that meet the criteria of the Globally Harmonized 
System and OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k), (q), and (t). It is a significant new 
use to manufacture or process the PMN substance without including the 
engineering controls/processes described in the TSCA section 5(e) 
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11547  Halogenated alkylbenzoic acid (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
halogenated alkylbenzoic acid (PMN P-19-176) is subject to reporting 
under this section for the significant new use described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (iv), and (3) through (6), and (b), 
and (c). When determining which persons are reasonably likely to be 
exposed as required for Sec.  721.63(a)(1) and (a)(4), engineering 
control measures (e.g., enclosure or confinement of the operation, 
general and local ventilation) or administrative control measures 
(e.g., workplace policies and procedures) shall be considered and 
implemented to prevent exposure, where feasible. For purposes of Sec.  
721.63(a)(5), respirators must provide a National Institute for 
Occupational Safety and Health (NIOSH) assigned protection factor (APF) 
of at least 10. For purposes of Sec.  721.63(a)(6), the airborne 
form(s) of the substance include particulate, gas/vapor (all substances 
in the gas form), combination gas/vapor and particulate (gas and 
liquid/solid physical states are present; a good example is paint spray 
mist, which contains both liquid droplets and vapor). For purposes of 
Sec.  721.63(b), the concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph 
(a)(2)(i) of this section, a manufacturer or processor may choose to 
follow the new chemical exposure limit (NCEL) provision listed in the 
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195 
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue 
NCELs as an alternative to Sec.  721.63 respirator requirements may 
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests 
to use the NCELs approach that are approved by EPA will be required to 
follow NCELs provisions comparable to those contained in the 
corresponding TSCA section 5(e) consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix) 
(eye and skin irritation), (g)(2)(i) through (v), and (5). For purposes 
of Sec.  721.72(e), the concentration is set at 1.0%. For purposes of 
Sec.  721.72(g)(1)(i), required human health hazard statements include 
acute toxicity, skin sensitization, serious eye damage, specific target 
organ toxicity, neurotoxicity, genetic toxicity, and reproductive 
toxicity. For purposes of Sec.  721.72(g)(2)(iv), use respiratory 
protection or maintain workplace airborne concentrations at or below an 
8-hour time-weighted average of 0.0195 mg/m\3\. Alternative hazard and 
warning statements that meet the criteria of the Globally Harmonized 
System and OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k), (q), and (t). It is a significant new 
use to manufacture or process the PMN substance without including the 
engineering controls/processes described in the TSCA section 5(e) 
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11548   Halogenated alkylbenzoic acid (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
halogenated alkylbenzoic acid (PMN P-19-177) is subject to reporting 
under this section for the significant new use described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (iv), and (3) through (6), and (b), 
and (c). When determining which persons are reasonably likely to be 
exposed as required for Sec.  721.63(a)(1) and (a)(4), engineering 
control measures (e.g., enclosure or confinement of the operation, 
general and local ventilation) or administrative control measures 
(e.g., workplace policies and procedures) shall be considered and 
implemented to prevent exposure, where feasible. For purposes of Sec.  
721.63(a)(5), respirators must provide a National Institute for 
Occupational Safety and Health (NIOSH) assigned protection factor (APF) 
of at least 10. For purposes of

[[Page 64304]]

Sec.  721.63(a)(6), the airborne form(s) of the substance include 
particulate, gas/vapor (all substances in the gas form), combination 
gas/vapor and particulate (gas and liquid/solid physical states are 
present; a good example is paint spray mist, which contains both liquid 
droplets and vapor). For purposes of Sec.  721.63(b), the concentration 
is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph 
(a)(2)(i) of this section, a manufacturer or processor may choose to 
follow the new chemical exposure limit (NCEL) provision listed in the 
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195 
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue 
NCELs as an alternative to Sec.  721.63 respirator requirements may 
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests 
to use the NCELs approach that are approved by EPA will be required to 
follow NCELs provisions comparable to those contained in the 
corresponding TSCA section 5(e) consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix) 
(eye and skin irritation), (g)(2)(i) through (v), and (5). For purposes 
of Sec.  721.72(e), the concentration is set at 1.0%. For purposes of 
Sec.  721.72(g)(1)(i), required human health hazard statements include 
acute toxicity, skin sensitization, serious eye damage, specific target 
organ toxicity, neurotoxicity, genetic toxicity, and reproductive 
toxicity. For purposes of Sec.  721.72(g)(2)(iv), use respiratory 
protection or maintain workplace airborne concentrations at or below an 
8-hour time-weighted average of 0.0195 mg/m\3\. Alternative hazard and 
warning statements that meet the criteria of the Globally Harmonized 
System and OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k), (q), and (t). It is a significant new 
use to manufacture or process the PMN substance without including the 
engineering controls/processes described in the TSCA section 5(e) 
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11549   Halogenated alkylbenzoic acid (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
halogenated alkylbenzoic acid (PMN P-19-178) is subject to reporting 
under this section for the significant new use described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (iv), and (3) through (6), (b), and 
(c). When determining which persons are reasonably likely to be exposed 
as required for Sec.  721.63(a)(1) and (a)(4), engineering control 
measures (e.g., enclosure or confinement of the operation, general and 
local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent 
exposure, where feasible. For purposes of Sec.  721.63(a)(5), 
respirators must provide a National Institute for Occupational Safety 
and Health (NIOSH) assigned protection factor (APF) of at least 10. For 
purposes of Sec.  721.63(a)(6), the airborne form(s) of the substance 
include particulate, gas/vapor (all substances in the gas form), 
combination gas/vapor and particulate (gas and liquid/solid physical 
states are present; a good example is paint spray mist, which contains 
both liquid droplets and vapor). For purposes of Sec.  721.63(b), the 
concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph 
(a)(2)(i) of this section, a manufacturer or processor may choose to 
follow the new chemical exposure limit (NCEL) provision listed in the 
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195 
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue 
NCELs as an alternative to Sec.  721.63 respirator requirements may 
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests 
to use the NCELs approach that are approved by EPA will be required to 
follow NCELs provisions comparable to those contained in the 
corresponding TSCA section 5(e) consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix) 
(eye and skin irritation), (g)(2)(i) through (v), and (5). For purposes 
of Sec.  721.72(e), the concentration is set at 1.0%. For purposes of 
Sec.  721.72(g)(1)(i), required human health hazard statements include 
acute toxicity, skin sensitization, serious eye damage, specific target 
organ toxicity, neurotoxicity, genetic toxicity, and reproductive 
toxicity. For purposes of Sec.  721.72(g)(2)(iv), use respiratory 
protection or maintain workplace airborne concentrations at or below an 
8-hour time-weighted average of 0.0195 mg/m\3\. Alternative hazard and 
warning statements that meet the criteria of the Globally Harmonized 
System and OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k), (q), and (t). It is a significant new 
use to manufacture or process the PMN substance without including the 
engineering controls/processes described in the TSCA section 5(e) 
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11550  Halogenated alkylbenzoic acid (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
halogenated alkylbenzoic acid (PMN P-19-179) is subject to reporting 
under this section for the significant new use described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Protection in the workplace. Requirements as specified in Sec.  
721.63(a)(1), (2)(i) and (iii), and (iv), and (3) through (6), and (b), 
and (c). When determining which persons are reasonably likely to be 
exposed as required for Sec.  721.63(a)(1) and (a)(4), engineering 
control measures (e.g., enclosure or confinement of the

[[Page 64305]]

operation, general and local ventilation) or administrative control 
measures (e.g., workplace policies and procedures) shall be considered 
and implemented to prevent exposure, where feasible. For purposes of 
Sec.  721.63(a)(5), respirators must provide a National Institute for 
Occupational Safety and Health (NIOSH) assigned protection factor (APF) 
of at least 10. For purposes of Sec.  721.63(a)(6), the airborne 
form(s) of the substance include particulate, gas/vapor (all substances 
in the gas form), combination gas/vapor and particulate (gas and 
liquid/solid physical states are present; a good example is paint spray 
mist, which contains both liquid droplets and vapor). For purposes of 
Sec.  721.63(b), the concentration is set at 1.0%.
    (A) As an alternative to the respirator requirements in paragraph 
(a)(2)(i) of this section, a manufacturer or processor may choose to 
follow the new chemical exposure limit (NCEL) provision listed in the 
TSCA section 5(e) consent order for this substance. The NCEL is 0.0195 
mg/m\3\ as an 8-hour time weighted average. Persons who wish to pursue 
NCELs as an alternative to Sec.  721.63 respirator requirements may 
request to do so under Sec.  721.30. Persons who Sec.  721.30 requests 
to use the NCELs approach that are approved by EPA will be required to 
follow NCELs provisions comparable to those contained in the 
corresponding TSCA section 5(e) consent order.
    (B) [Reserved]
    (ii) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix) 
(eye and skin irritation), (g)(2)(i) through (v), and (5). For purposes 
of Sec.  721.72(e), the concentration is set at 1.0%. For purposes of 
Sec.  721.72(g)(1)(i), required human health hazard statements include 
acute toxicity, skin sensitization, serious eye damage, specific target 
organ toxicity, neurotoxicity, genetic toxicity, and reproductive 
toxicity. For purposes of Sec.  721.72(g)(2)(iv), use respiratory 
protection or maintain workplace airborne concentrations at or below an 
8-hour time-weighted average of 0.0195 mg/m\3\. Alternative hazard and 
warning statements that meet the criteria of the Globally Harmonized 
System and OSHA Hazard Communication Standard may be used.
    (iii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k), (q), and (t). It is a significant new 
use to manufacture or process the PMN substance without including the 
engineering controls/processes described in the TSCA section 5(e) 
consent order for the substance.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (i) are applicable to manufacturers and processors 
of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(iii) 
of this section.

Sec.  721.11551  Halogenated sodium benzoate (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
halogenated sodium benzoate (PMN P-19-180) is subject to reporting 
under this section for the significant new use described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix) 
(eye and skin irritation), (g)(2)(i) through (iii), and (5). For 
purposes of Sec.  721.72(e), the concentration is set at 1.0%. For 
purposes of Sec.  721.72(g)(1)(i), required human health hazard 
statements include acute toxicity, skin sensitization, serious eye 
damage, specific target organ toxicity, neurotoxicity, genetic 
toxicity, and reproductive toxicity. Alternative hazard and warning 
statements that meet the criteria of the Globally Harmonized System and 
OSHA Hazard Communication Standard may be used.
    (ii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k) and (q). It is a significant new use to 
manufacture or process the PMN substance without including the 
engineering controls/processes described in the TSCA section 5(e) 
consent order for the substance. It is a significant new use to 
manufacture or use the PMN substance other than in liquid formulations.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (c) and (f) through (i) are applicable to 
manufacturers and processors of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(ii) of 
this section.

Sec.  721.11552  Halogenated sodium benzoate (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
halogenated sodium benzoate (PMN P-19-181) is subject to reporting 
under this section for the significant new use described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix) 
(eye and skin irritation), (g)(2)(i) through (iii), and (5). For 
purposes of Sec.  721.72(e), the concentration is set at 1.0%. For 
purposes of Sec.  721.72(g)(1)(i), required human health hazard 
statements include acute toxicity, skin sensitization, serious eye 
damage, specific target organ toxicity, neurotoxicity, genetic 
toxicity, and reproductive toxicity. Alternative hazard and warning 
statements that meet the criteria of the Globally Harmonized System and 
OSHA Hazard Communication Standard may be used.
    (ii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k) and (q). It is a significant new use to 
manufacture or process the PMN substance without including the 
engineering controls/processes described in the TSCA section 5(e) 
consent order for the substance. It is a significant new use to 
manufacture or use the PMN substance other than in liquid formulations.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (c) and (f) through (i) are applicable to 
manufacturers and processors of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(ii) of 
this section.

[[Page 64306]]

Sec.  721.11553   Halogenated sodium benzoate (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
halogenated sodium benzoate (PMN P-19-182) is subject to reporting 
under this section for the significant new use described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix) 
(eye and skin irritation), (g)(2)(i) through (iii), and (5). For 
purposes of Sec.  721.72(e), the concentration is set at 1.0%. For 
purposes of Sec.  721.72(g)(1)(i), required human health hazard 
statements include acute toxicity, skin sensitization, serious eye 
damage, specific target organ toxicity, neurotoxicity, genetic 
toxicity, and reproductive toxicity. Alternative hazard and warning 
statements that meet the criteria of the Globally Harmonized System and 
OSHA Hazard Communication Standard may be used.
    (ii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k) and (q). It is a significant new use to 
manufacture or process the PMN substance without including the 
engineering controls/processes described in the TSCA section 5(e) 
consent order for the substance. It is a significant new use to 
manufacture or use the PMN substance other than in liquid formulations.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (c) and (f) through (i) are applicable to 
manufacturers and processors of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(ii) of 
this section.

Sec.  721.11554  Halogenated sodium alkylbenzoate (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
halogenated sodium alkylbenzoate (PMN P-19-184) is subject to reporting 
under this section for the significant new use described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix) 
(eye and skin irritation), (g)(2)(i) through (iii), and (5). For 
purposes of Sec.  721.72(e), the concentration is set at 1.0%. For 
purposes of Sec.  721.72(g)(1)(i), required human health hazard 
statements include acute toxicity, skin sensitization, serious eye 
damage, specific target organ toxicity, neurotoxicity, genetic 
toxicity, and reproductive toxicity. Alternative hazard and warning 
statements that meet the criteria of the Globally Harmonized System and 
OSHA Hazard Communication Standard may be used.
    (ii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k) and (q). It is a significant new use to 
manufacture or process the PMN substance without including the 
engineering controls/processes described in the TSCA section 5(e) 
consent order for the substance. It is a significant new use to 
manufacture or use the PMN substance other than in liquid formulations.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (c) and (f) through (i) are applicable to 
manufacturers and processors of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(ii) of 
this section.

Sec.  721.11555  Halogenated sodium alkylbenzoate (generic).

    (a) Chemical substance and significant new uses subject to 
reporting. (1) The chemical substance generically identified as 
halogenated sodium alkylbenzoate (PMN P-19-187) is subject to reporting 
under this section for the significant new use described in paragraph 
(a)(2) of this section.
    (2) The significant new uses are:
    (i) Hazard communication. Requirements as specified in Sec.  
721.72(a) through (e), (f), (g)(1)(ii) through (iv), (vi), and (ix) 
(eye and skin irritation), (g)(2)(i) through (iii), and (5). For 
purposes of Sec.  721.72(e), the concentration is set at 1.0%. For 
purposes of Sec.  721.72(g)(1)(i), required human health hazard 
statements include acute toxicity, skin sensitization, serious eye 
damage, specific target organ toxicity, neurotoxicity, genetic 
toxicity, and reproductive toxicity. Alternative hazard and warning 
statements that meet the criteria of the Globally Harmonized System and 
OSHA Hazard Communication Standard may be used.
    (ii) Industrial, commercial, and consumer activities. Requirements 
as specified in Sec.  721.80(k) and (q). It is a significant new use to 
manufacture or process the PMN substance without including the 
engineering controls/processes described in the TSCA section 5(e) 
consent order for the substance. It is a significant new use to 
manufacture or use the PMN substance other than in liquid formulations.
    (b) Specific requirements. The provision of subpart A of this part 
apply to this section except as modified by this paragraph (b).
    (1) Recordkeeping. Recordkeeping requirements as specified in Sec.  
721.125(a) through (c) and (f) through (i) are applicable to 
manufacturers and processors of this substance.
    (2) Limitations or revocation of certain modification requirements. 
The provisions of Sec.  721.185 apply to this section.
    (3) Determining whether a specific use is subject to this section. 
The provisions of Sec.  721.1725(b)(1) apply to paragraph (a)(2)(ii) of 
this section.

[FR Doc. 2020-21471 Filed 10-8-20; 8:45 am]
 BILLING CODE 6560-50-P